id	sid	tid	token	lemma	pos
mkg-1066	1	1	effect	effect	NOUN
mkg-1066	1	2	of	of	ADP
mkg-1066	1	3	combination	combination	NOUN
mkg-1066	1	4	antiretroviral	antiretroviral	ADJ
mkg-1066	1	5	therapy	therapy	NOUN
mkg-1066	1	6	on	on	ADP
mkg-1066	1	7	the	the	DET
mkg-1066	1	8	frequency	frequency	NOUN
mkg-1066	1	9	of	of	ADP
mkg-1066	1	10	oral	oral	ADJ
mkg-1066	1	11	candidiasis	candidiasis	NOUN
mkg-1066	1	12	in	in	ADP
mkg-1066	1	13	hiv	hiv	PROPN
mkg-1066	1	14	/	/	SYM
mkg-1066	1	15	aids	aids	PROPN
mkg-1066	1	16	patient	patient	PROPN
mkg-1066	1	17	sayuti	sayuti	PROPN
mkg-1066	1	18	hasibuan	hasibuan	PROPN
mkg-1066	1	19	department	department	PROPN
mkg-1066	1	20	of	of	ADP
mkg-1066	1	21	oral	oral	ADJ
mkg-1066	1	22	medicine	medicine	NOUN
mkg-1066	1	23	dentistry	dentistry	NOUN
mkg-1066	1	24	faculty	faculty	NOUN
mkg-1066	1	25	of	of	ADP
mkg-1066	1	26	university	university	PROPN
mkg-1066	1	27	of	of	ADP
mkg-1066	1	28	north	north	PROPN
mkg-1066	1	29	sumatera	sumatera	PROPN
mkg-1066	1	30	medan	medan	PROPN
mkg-1066	1	31	indonesia	indonesia	PROPN
mkg-1066	1	32	abstract	abstract	ADJ
mkg-1066	1	33	oral	oral	ADJ
mkg-1066	1	34	candidiasis	candidiasis	NOUN
mkg-1066	1	35	is	be	AUX
mkg-1066	1	36	one	one	NUM
mkg-1066	1	37	of	of	ADP
mkg-1066	1	38	the	the	DET
mkg-1066	1	39	most	most	ADV
mkg-1066	1	40	common	common	ADJ
mkg-1066	1	41	opportunistic	opportunistic	ADJ
mkg-1066	1	42	infections	infection	NOUN
mkg-1066	1	43	in	in	ADP
mkg-1066	1	44	hiv	hiv	PROPN
mkg-1066	1	45	/	/	SYM
mkg-1066	1	46	aids	aids	PROPN
mkg-1066	1	47	patients	patient	NOUN
mkg-1066	1	48	.	.	PUNCT
mkg-1066	2	1	it	it	PRON
mkg-1066	2	2	serves	serve	VERB
mkg-1066	2	3	as	as	ADP
mkg-1066	2	4	important	important	ADJ
mkg-1066	2	5	markers	marker	NOUN
mkg-1066	2	6	of	of	ADP
mkg-1066	2	7	hiv	hiv	PROPN
mkg-1066	2	8	infection	infection	NOUN
mkg-1066	2	9	,	,	PUNCT
mkg-1066	2	10	viral	viral	ADJ
mkg-1066	2	11	load	load	NOUN
mkg-1066	2	12	,	,	PUNCT
mkg-1066	2	13	and	and	CCONJ
mkg-1066	2	14	cd4	cd4	PROPN
mkg-1066	2	15	cells	cell	NOUN
mkg-1066	2	16	count	count	VERB
mkg-1066	2	17	in	in	ADP
mkg-1066	2	18	the	the	DET
mkg-1066	2	19	blood	blood	NOUN
mkg-1066	2	20	and	and	CCONJ
mkg-1066	2	21	predict	predict	VERB
mkg-1066	2	22	disease	disease	NOUN
mkg-1066	2	23	progression	progression	NOUN
mkg-1066	2	24	to	to	AUX
mkg-1066	2	25	aids	aids	PROPN
mkg-1066	2	26	.	.	PUNCT
mkg-1066	3	1	the	the	DET
mkg-1066	3	2	development	development	NOUN
mkg-1066	3	3	of	of	ADP
mkg-1066	3	4	oral	oral	ADJ
mkg-1066	3	5	candidiasis	candidiasis	NOUN
mkg-1066	3	6	in	in	ADP
mkg-1066	3	7	hiv	hiv	PROPN
mkg-1066	3	8	/	/	SYM
mkg-1066	3	9	aids	aids	PROPN
mkg-1066	3	10	patients	patient	NOUN
mkg-1066	3	11	associated	associate	VERB
mkg-1066	3	12	by	by	ADP
mkg-1066	3	13	imbalances	imbalance	NOUN
mkg-1066	3	14	between	between	ADP
mkg-1066	3	15	candida	candida	PROPN
mkg-1066	3	16	and	and	CCONJ
mkg-1066	3	17	impaired	impaired	ADJ
mkg-1066	3	18	host	host	NOUN
mkg-1066	3	19	immune	immune	ADJ
mkg-1066	3	20	defenses	defense	NOUN
mkg-1066	3	21	that	that	PRON
mkg-1066	3	22	caused	cause	VERB
mkg-1066	3	23	by	by	ADP
mkg-1066	3	24	decreased	decrease	VERB
mkg-1066	3	25	of	of	ADP
mkg-1066	3	26	cd4	cd4	PROPN
mkg-1066	3	27	cell	cell	NOUN
mkg-1066	3	28	counts	count	NOUN
mkg-1066	3	29	and	and	CCONJ
mkg-1066	3	30	the	the	DET
mkg-1066	3	31	increased	increase	VERB
mkg-1066	3	32	of	of	ADP
mkg-1066	3	33	plasma	plasma	NOUN
mkg-1066	3	34	hiv	hiv	PROPN
mkg-1066	3	35	-	-	PUNCT
mkg-1066	3	36	viral	viral	ADJ
mkg-1066	3	37	load	load	NOUN
mkg-1066	3	38	.	.	PUNCT
mkg-1066	4	1	since	since	SCONJ
mkg-1066	4	2	the	the	DET
mkg-1066	4	3	introduction	introduction	NOUN
mkg-1066	4	4	of	of	ADP
mkg-1066	4	5	antiretroviral	antiretroviral	ADJ
mkg-1066	4	6	therapy	therapy	NOUN
mkg-1066	4	7	combination	combination	NOUN
mkg-1066	4	8	,	,	PUNCT
mkg-1066	4	9	commonly	commonly	ADV
mkg-1066	4	10	known	know	VERB
mkg-1066	4	11	as	as	ADP
mkg-1066	4	12	highly	highly	ADV
mkg-1066	4	13	active	active	ADJ
mkg-1066	4	14	antiretroviral	antiretroviral	ADJ
mkg-1066	4	15	therapy	therapy	NOUN
mkg-1066	4	16	(	(	PUNCT
mkg-1066	4	17	haart	haart	PROPN
mkg-1066	4	18	)	)	PUNCT
mkg-1066	4	19	,	,	PUNCT
mkg-1066	4	20	it	it	PRON
mkg-1066	4	21	has	have	AUX
mkg-1066	4	22	been	be	AUX
mkg-1066	4	23	observed	observe	VERB
mkg-1066	4	24	that	that	SCONJ
mkg-1066	4	25	certain	certain	ADJ
mkg-1066	4	26	oral	oral	ADJ
mkg-1066	4	27	lesions	lesion	NOUN
mkg-1066	4	28	,	,	PUNCT
mkg-1066	4	29	such	such	ADJ
mkg-1066	4	30	as	as	ADP
mkg-1066	4	31	oral	oral	ADJ
mkg-1066	4	32	candidiasis	candidiasis	NOUN
mkg-1066	4	33	as	as	SCONJ
mkg-1066	4	34	declined	decline	VERB
mkg-1066	4	35	.	.	PUNCT
mkg-1066	5	1	the	the	DET
mkg-1066	5	2	aim	aim	NOUN
mkg-1066	5	3	of	of	ADP
mkg-1066	5	4	this	this	DET
mkg-1066	5	5	paper	paper	NOUN
mkg-1066	5	6	is	be	AUX
mkg-1066	5	7	to	to	PART
mkg-1066	5	8	review	review	VERB
mkg-1066	5	9	the	the	DET
mkg-1066	5	10	mechanism	mechanism	NOUN
mkg-1066	5	11	of	of	ADP
mkg-1066	5	12	combination	combination	NOUN
mkg-1066	5	13	antiretroviral	antiretroviral	ADJ
mkg-1066	5	14	therapy	therapy	NOUN
mkg-1066	5	15	influenced	influence	VERB
mkg-1066	5	16	the	the	DET
mkg-1066	5	17	frequency	frequency	NOUN
mkg-1066	5	18	of	of	ADP
mkg-1066	5	19	oral	oral	ADJ
mkg-1066	5	20	candidiasis	candidiasis	NOUN
mkg-1066	5	21	in	in	ADP
mkg-1066	5	22	hiv	hiv	PROPN
mkg-1066	5	23	/	/	SYM
mkg-1066	5	24	aids	aids	PROPN
mkg-1066	5	25	patient	patient	NOUN
mkg-1066	5	26	.	.	PUNCT
mkg-1066	6	1	we	we	PRON
mkg-1066	6	2	conclude	conclude	VERB
mkg-1066	6	3	that	that	DET
mkg-1066	6	4	combination	combination	NOUN
mkg-1066	6	5	antiretroviral	antiretroviral	ADJ
mkg-1066	6	6	therapy	therapy	NOUN
mkg-1066	6	7	generally	generally	ADV
mkg-1066	6	8	reduced	reduce	VERB
mkg-1066	6	9	the	the	DET
mkg-1066	6	10	frequency	frequency	NOUN
mkg-1066	6	11	and	and	CCONJ
mkg-1066	6	12	severity	severity	NOUN
mkg-1066	6	13	of	of	ADP
mkg-1066	6	14	oral	oral	ADJ
mkg-1066	6	15	candidiasis	candidiasis	NOUN
mkg-1066	6	16	in	in	ADP
mkg-1066	6	17	hiv	hiv	PROPN
mkg-1066	6	18	/	/	SYM
mkg-1066	6	19	aids	aids	PROPN
mkg-1066	6	20	patient	patient	NOUN
mkg-1066	6	21	.	.	PUNCT
mkg-1066	7	1	key	key	ADJ
mkg-1066	7	2	words	word	NOUN
mkg-1066	7	3	:	:	PUNCT
mkg-1066	7	4	hiv	hiv	PROPN
mkg-1066	7	5	/	/	SYM
mkg-1066	7	6	aids	aids	PROPN
mkg-1066	7	7	,	,	PUNCT
mkg-1066	7	8	oral	oral	ADJ
mkg-1066	7	9	candidiasis	candidiasis	NOUN
mkg-1066	7	10	,	,	PUNCT
mkg-1066	7	11	antiretroviral	antiretroviral	ADJ
mkg-1066	7	12	,	,	PUNCT
mkg-1066	7	13	haart	haart	PROPN
mkg-1066	7	14	correspondence	correspondence	NOUN
mkg-1066	7	15	:	:	PUNCT
mkg-1066	7	16	sayuti	sayuti	PROPN
mkg-1066	7	17	hasibuan	hasibuan	PROPN
mkg-1066	7	18	,	,	PUNCT
mkg-1066	7	19	c	c	X
mkg-1066	7	20	/	/	SYM
mkg-1066	7	21	o	o	NOUN
mkg-1066	7	22	:	:	PUNCT
mkg-1066	7	23	bagian	bagian	PROPN
mkg-1066	7	24	penyakit	penyakit	PROPN
mkg-1066	7	25	mulut	mulut	PROPN
mkg-1066	7	26	.	.	PUNCT
mkg-1066	8	1	fakultas	fakultas	PROPN
mkg-1066	8	2	kedokteran	kedokteran	PROPN
mkg-1066	8	3	gigi	gigi	PROPN
mkg-1066	8	4	universitas	universitas	PROPN
mkg-1066	8	5	sumatera	sumatera	PROPN
mkg-1066	8	6	utara	utara	NOUN
mkg-1066	8	7	.	.	PUNCT
mkg-1066	9	1	jl	jl	PROPN
mkg-1066	9	2	.	.	PUNCT
mkg-1066	9	3	alumni	alumnus	NOUN
mkg-1066	9	4	no	no	INTJ
mkg-1066	9	5	.	.	NOUN
mkg-1066	9	6	2	2	NUM
mkg-1066	9	7	,	,	PUNCT
mkg-1066	9	8	kampus	kampus	PROPN
mkg-1066	9	9	usu	usu	PROPN
mkg-1066	9	10	medan	medan	PROPN
mkg-1066	9	11	,	,	PUNCT
mkg-1066	9	12	indonesia	indonesia	PROPN
mkg-1066	9	13	.	.	PUNCT
mkg-1066	10	1	introduction	introduction	NOUN
mkg-1066	10	2	acquired	acquire	VERB
mkg-1066	10	3	immune	immune	ADJ
mkg-1066	10	4	deficiency	deficiency	NOUN
mkg-1066	10	5	syndrome	syndrome	NOUN
mkg-1066	10	6	(	(	PUNCT
mkg-1066	10	7	aids	aids	PROPN
mkg-1066	10	8	)	)	PUNCT
mkg-1066	10	9	is	be	AUX
mkg-1066	10	10	caused	cause	VERB
mkg-1066	10	11	by	by	ADP
mkg-1066	10	12	human	human	ADJ
mkg-1066	10	13	immunodeficiency	immunodeficiency	NOUN
mkg-1066	10	14	virus	virus	NOUN
mkg-1066	10	15	(	(	PUNCT
mkg-1066	10	16	hiv	hiv	PROPN
mkg-1066	10	17	)	)	PUNCT
mkg-1066	10	18	.	.	PUNCT
mkg-1066	11	1	this	this	DET
mkg-1066	11	2	virus	virus	NOUN
mkg-1066	11	3	will	will	AUX
mkg-1066	11	4	be	be	AUX
mkg-1066	11	5	binding	bind	VERB
mkg-1066	11	6	with	with	ADP
mkg-1066	11	7	the	the	DET
mkg-1066	11	8	surface	surface	NOUN
mkg-1066	11	9	of	of	ADP
mkg-1066	11	10	cd4	cd4	PROPN
mkg-1066	11	11	cells	cell	NOUN
mkg-1066	11	12	on	on	ADP
mkg-1066	11	13	the	the	DET
mkg-1066	11	14	helper	helper	NOUN
mkg-1066	11	15	t	t	PROPN
mkg-1066	11	16	lymphocytes	lymphocyte	VERB
mkg-1066	11	17	(	(	PUNCT
mkg-1066	11	18	t4	t4	PROPN
mkg-1066	11	19	lymphocyte	lymphocyte	PROPN
mkg-1066	11	20	)	)	PUNCT
mkg-1066	11	21	,	,	PUNCT
mkg-1066	11	22	subsequently	subsequently	ADV
mkg-1066	11	23	interacts	interact	VERB
mkg-1066	11	24	and	and	CCONJ
mkg-1066	11	25	infects	infect	VERB
mkg-1066	11	26	healthy	healthy	ADJ
mkg-1066	11	27	cells	cell	NOUN
mkg-1066	11	28	.	.	PUNCT
mkg-1066	12	1	furthermore	furthermore	ADV
mkg-1066	12	2	,	,	PUNCT
mkg-1066	12	3	the	the	DET
mkg-1066	12	4	population	population	NOUN
mkg-1066	12	5	of	of	ADP
mkg-1066	12	6	helper	helper	NOUN
mkg-1066	12	7	t	t	PROPN
mkg-1066	12	8	lymphocytes	lymphocyte	VERB
mkg-1066	12	9	/	/	SYM
mkg-1066	12	10	cd4	cd4	PROPN
mkg-1066	12	11	cells	cell	NOUN
mkg-1066	12	12	decreased	decrease	VERB
mkg-1066	12	13	and	and	CCONJ
mkg-1066	12	14	viral	viral	ADJ
mkg-1066	12	15	load	load	NOUN
mkg-1066	12	16	increased	increase	VERB
mkg-1066	12	17	,	,	PUNCT
mkg-1066	12	18	causing	cause	VERB
mkg-1066	12	19	impaired	impair	VERB
mkg-1066	12	20	of	of	ADP
mkg-1066	12	21	immune	immune	ADJ
mkg-1066	12	22	system.1,2	system.1,2	PROPN
mkg-1066	12	23	once	once	SCONJ
mkg-1066	12	24	a	a	DET
mkg-1066	12	25	retrovirus	retrovirus	NOUN
mkg-1066	12	26	hiv	hiv	PROPN
mkg-1066	12	27	had	have	AUX
mkg-1066	12	28	been	be	AUX
mkg-1066	12	29	identified	identify	VERB
mkg-1066	12	30	as	as	ADP
mkg-1066	12	31	an	an	DET
mkg-1066	12	32	agent	agent	NOUN
mkg-1066	12	33	caused	cause	VERB
mkg-1066	12	34	of	of	ADP
mkg-1066	12	35	aids	aid	NOUN
mkg-1066	12	36	,	,	PUNCT
mkg-1066	12	37	there	there	PRON
mkg-1066	12	38	has	have	AUX
mkg-1066	12	39	been	be	AUX
mkg-1066	12	40	a	a	DET
mkg-1066	12	41	concerted	concerted	ADJ
mkg-1066	12	42	effort	effort	NOUN
mkg-1066	12	43	on	on	ADP
mkg-1066	12	44	the	the	DET
mkg-1066	12	45	part	part	NOUN
mkg-1066	12	46	of	of	ADP
mkg-1066	12	47	physicians	physician	NOUN
mkg-1066	12	48	,	,	PUNCT
mkg-1066	12	49	scientists	scientist	NOUN
mkg-1066	12	50	and	and	CCONJ
mkg-1066	12	51	pharmaceutical	pharmaceutical	NOUN
mkg-1066	12	52	industry	industry	NOUN
mkg-1066	12	53	to	to	PART
mkg-1066	12	54	discover	discover	VERB
mkg-1066	12	55	and	and	CCONJ
mkg-1066	12	56	develop	develop	VERB
mkg-1066	12	57	compound	compound	NOUN
mkg-1066	12	58	that	that	PRON
mkg-1066	12	59	are	be	AUX
mkg-1066	12	60	effective	effective	ADJ
mkg-1066	12	61	in	in	ADP
mkg-1066	12	62	inhibiting	inhibit	VERB
mkg-1066	12	63	hiv	hiv	PROPN
mkg-1066	12	64	replication	replication	NOUN
mkg-1066	12	65	.	.	PUNCT
mkg-1066	13	1	initially	initially	ADV
mkg-1066	13	2	,	,	PUNCT
mkg-1066	13	3	were	be	AUX
mkg-1066	13	4	introduced	introduce	VERB
mkg-1066	13	5	in	in	ADP
mkg-1066	13	6	1997	1997	NUM
mkg-1066	13	7	,	,	PUNCT
mkg-1066	13	8	treatment	treatment	NOUN
mkg-1066	13	9	for	for	ADP
mkg-1066	13	10	hiv	hiv	PROPN
mkg-1066	13	11	-	-	PUNCT
mkg-1066	13	12	infected	infect	VERB
mkg-1066	13	13	patients	patient	NOUN
mkg-1066	13	14	relied	rely	VERB
mkg-1066	13	15	on	on	ADP
mkg-1066	13	16	nucleoside	nucleoside	NOUN
mkg-1066	13	17	reverse	reverse	ADJ
mkg-1066	13	18	transcriptase	transcriptase	NOUN
mkg-1066	13	19	inhibitor	inhibitor	NOUN
mkg-1066	13	20	(	(	PUNCT
mkg-1066	13	21	nrti	nrti	PROPN
mkg-1066	13	22	)	)	PUNCT
mkg-1066	13	23	,	,	PUNCT
mkg-1066	13	24	namely	namely	ADV
mkg-1066	13	25	zidovudine	zidovudine	PROPN
mkg-1066	13	26	(	(	PUNCT
mkg-1066	13	27	azt	azt	PROPN
mkg-1066	13	28	)	)	PUNCT
mkg-1066	13	29	.	.	PUNCT
mkg-1066	14	1	similar	similar	ADJ
mkg-1066	14	2	to	to	ADP
mkg-1066	14	3	nrti	nrti	PROPN
mkg-1066	14	4	,	,	PUNCT
mkg-1066	14	5	were	be	AUX
mkg-1066	14	6	introduced	introduce	VERB
mkg-1066	14	7	non	non	ADJ
mkg-1066	14	8	-	-	ADJ
mkg-1066	14	9	nucleoside	nucleoside	ADJ
mkg-1066	14	10	reverse	reverse	ADJ
mkg-1066	14	11	transcriptase	transcriptase	NOUN
mkg-1066	14	12	inhibitor	inhibitor	NOUN
mkg-1066	14	13	(	(	PUNCT
mkg-1066	14	14	nnrti	nnrti	PROPN
mkg-1066	14	15	)	)	PUNCT
mkg-1066	14	16	.	.	PUNCT
mkg-1066	15	1	furthermore	furthermore	ADV
mkg-1066	15	2	,	,	PUNCT
mkg-1066	15	3	protease	protease	NOUN
mkg-1066	15	4	inhibitor	inhibitor	NOUN
mkg-1066	15	5	(	(	PUNCT
mkg-1066	15	6	pi	pi	NOUN
mkg-1066	15	7	)	)	PUNCT
mkg-1066	15	8	were	be	AUX
mkg-1066	15	9	introduced	introduce	VERB
mkg-1066	15	10	as	as	ADP
mkg-1066	15	11	a	a	DET
mkg-1066	15	12	new	new	ADJ
mkg-1066	15	13	drug	drug	NOUN
mkg-1066	15	14	in	in	ADP
mkg-1066	15	15	1996	1996	NUM
mkg-1066	15	16	.	.	PUNCT
mkg-1066	16	1	at	at	ADP
mkg-1066	16	2	present	present	ADJ
mkg-1066	16	3	,	,	PUNCT
mkg-1066	16	4	the	the	DET
mkg-1066	16	5	recommended	recommend	VERB
mkg-1066	16	6	treatment	treatment	NOUN
mkg-1066	16	7	for	for	ADP
mkg-1066	16	8	hiv	hiv	PROPN
mkg-1066	16	9	infection	infection	NOUN
mkg-1066	16	10	is	be	AUX
mkg-1066	16	11	highly	highly	ADV
mkg-1066	16	12	active	active	ADJ
mkg-1066	16	13	antiretroviral	antiretroviral	ADJ
mkg-1066	16	14	therapy	therapy	NOUN
mkg-1066	16	15	(	(	PUNCT
mkg-1066	16	16	haart	haart	PROPN
mkg-1066	16	17	)	)	PUNCT
mkg-1066	16	18	which	which	PRON
mkg-1066	16	19	consists	consist	VERB
mkg-1066	16	20	of	of	ADP
mkg-1066	16	21	a	a	DET
mkg-1066	16	22	combination	combination	NOUN
mkg-1066	16	23	of	of	ADP
mkg-1066	16	24	nrti	nrti	NOUN
mkg-1066	16	25	,	,	PUNCT
mkg-1066	16	26	nnrti	nnrti	NOUN
mkg-1066	16	27	or	or	CCONJ
mkg-1066	16	28	pi.3,4,5	pi.3,4,5	NOUN
mkg-1066	16	29	since	since	SCONJ
mkg-1066	16	30	the	the	DET
mkg-1066	16	31	early	early	ADJ
mkg-1066	16	32	reported	report	VERB
mkg-1066	16	33	cases	case	NOUN
mkg-1066	16	34	of	of	ADP
mkg-1066	16	35	aids	aid	NOUN
mkg-1066	16	36	in	in	ADP
mkg-1066	16	37	the	the	DET
mkg-1066	16	38	early	early	ADJ
mkg-1066	16	39	1980s	1980s	NUM
mkg-1066	16	40	,	,	PUNCT
mkg-1066	16	41	a	a	DET
mkg-1066	16	42	number	number	NOUN
mkg-1066	16	43	of	of	ADP
mkg-1066	16	44	oral	oral	ADJ
mkg-1066	16	45	lesions	lesion	NOUN
mkg-1066	16	46	,	,	PUNCT
mkg-1066	16	47	including	include	VERB
mkg-1066	16	48	oral	oral	ADJ
mkg-1066	16	49	candidiasis	candidiasis	NOUN
mkg-1066	16	50	have	have	AUX
mkg-1066	16	51	been	be	AUX
mkg-1066	16	52	associated	associate	VERB
mkg-1066	16	53	with	with	ADP
mkg-1066	16	54	hiv	hiv	PROPN
mkg-1066	16	55	infection	infection	NOUN
mkg-1066	16	56	.	.	PUNCT
mkg-1066	17	1	oral	oral	ADJ
mkg-1066	17	2	candidiasis	candidiasis	NOUN
mkg-1066	17	3	are	be	AUX
mkg-1066	17	4	reported	report	VERB
mkg-1066	17	5	to	to	PART
mkg-1066	17	6	have	have	VERB
mkg-1066	17	7	an	an	DET
mkg-1066	17	8	increased	increase	VERB
mkg-1066	17	9	prevalence	prevalence	NOUN
mkg-1066	17	10	among	among	ADP
mkg-1066	17	11	patients	patient	NOUN
mkg-1066	17	12	with	with	ADP
mkg-1066	17	13	hiv	hiv	PROPN
mkg-1066	17	14	-	-	PUNCT
mkg-1066	17	15	infected	infect	VERB
mkg-1066	17	16	or	or	CCONJ
mkg-1066	17	17	aids	aid	NOUN
mkg-1066	17	18	and	and	CCONJ
mkg-1066	17	19	has	have	AUX
mkg-1066	17	20	been	be	AUX
mkg-1066	17	21	used	use	VERB
mkg-1066	17	22	as	as	ADP
mkg-1066	17	23	diagnostic	diagnostic	ADJ
mkg-1066	17	24	and	and	CCONJ
mkg-1066	17	25	prognostic	prognostic	ADJ
mkg-1066	17	26	markers	marker	NOUN
mkg-1066	17	27	for	for	ADP
mkg-1066	17	28	the	the	DET
mkg-1066	17	29	disease.6,7,8	disease.6,7,8	X
mkg-1066	17	30	the	the	DET
mkg-1066	17	31	introduction	introduction	NOUN
mkg-1066	17	32	of	of	ADP
mkg-1066	17	33	combination	combination	NOUN
mkg-1066	17	34	therapies	therapy	NOUN
mkg-1066	17	35	,	,	PUNCT
mkg-1066	17	36	called	call	VERB
mkg-1066	17	37	haart	haart	PROPN
mkg-1066	17	38	as	as	ADP
mkg-1066	17	39	a	a	DET
mkg-1066	17	40	treatment	treatment	NOUN
mkg-1066	17	41	for	for	ADP
mkg-1066	17	42	hiv	hiv	PROPN
mkg-1066	17	43	-	-	PUNCT
mkg-1066	17	44	infected	infect	VERB
mkg-1066	17	45	patients	patient	NOUN
mkg-1066	17	46	in	in	ADP
mkg-1066	17	47	the	the	DET
mkg-1066	17	48	mid-1990s	mid-1990	NOUN
mkg-1066	17	49	,	,	PUNCT
mkg-1066	17	50	however	however	ADV
mkg-1066	17	51	has	have	AUX
mkg-1066	17	52	been	be	AUX
mkg-1066	17	53	accompanied	accompany	VERB
mkg-1066	17	54	by	by	ADP
mkg-1066	17	55	multiple	multiple	ADJ
mkg-1066	17	56	report	report	NOUN
mkg-1066	17	57	of	of	ADP
mkg-1066	17	58	reduction	reduction	NOUN
mkg-1066	17	59	in	in	ADP
mkg-1066	17	60	the	the	DET
mkg-1066	17	61	incidence	incidence	NOUN
mkg-1066	17	62	and	and	CCONJ
mkg-1066	17	63	prevalence	prevalence	NOUN
mkg-1066	17	64	of	of	ADP
mkg-1066	17	65	oral	oral	ADJ
mkg-1066	17	66	mucosal	mucosal	NOUN
mkg-1066	17	67	diseases	disease	NOUN
mkg-1066	17	68	including	include	VERB
mkg-1066	17	69	oral	oral	ADJ
mkg-1066	17	70	candidiasis.6	candidiasis.6	PROPN
mkg-1066	17	71	for	for	ADP
mkg-1066	17	72	instance	instance	NOUN
mkg-1066	17	73	,	,	PUNCT
mkg-1066	17	74	patton	patton	PROPN
mkg-1066	17	75	et	et	PROPN
mkg-1066	17	76	al	al	PROPN
mkg-1066	17	77	from	from	ADP
mkg-1066	17	78	united	united	PROPN
mkg-1066	17	79	states	states	PROPN
mkg-1066	17	80	(	(	PUNCT
mkg-1066	17	81	1995–1999	1995–1999	NUM
mkg-1066	17	82	)	)	PUNCT
mkg-1066	17	83	have	have	AUX
mkg-1066	17	84	reported	report	VERB
mkg-1066	17	85	significant	significant	ADJ
mkg-1066	17	86	decrease	decrease	NOUN
mkg-1066	17	87	in	in	ADP
mkg-1066	17	88	the	the	DET
mkg-1066	17	89	prevalence	prevalence	NOUN
mkg-1066	17	90	of	of	ADP
mkg-1066	17	91	oral	oral	ADJ
mkg-1066	17	92	candidiasis	candidiasis	NOUN
mkg-1066	17	93	from	from	ADP
mkg-1066	17	94	20.3	20.3	NUM
mkg-1066	17	95	%	%	NOUN
mkg-1066	17	96	to	to	ADP
mkg-1066	17	97	16.7%.9	16.7%.9	NUM
mkg-1066	17	98	in	in	ADP
mkg-1066	17	99	this	this	DET
mkg-1066	17	100	paper	paper	NOUN
mkg-1066	17	101	,	,	PUNCT
mkg-1066	17	102	will	will	AUX
mkg-1066	17	103	be	be	AUX
mkg-1066	17	104	review	review	NOUN
mkg-1066	17	105	about	about	ADP
mkg-1066	17	106	combination	combination	NOUN
mkg-1066	17	107	antiretroviral	antiretroviral	ADJ
mkg-1066	17	108	therapy	therapy	NOUN
mkg-1066	17	109	and	and	CCONJ
mkg-1066	17	110	its	its	PRON
mkg-1066	17	111	effect	effect	NOUN
mkg-1066	17	112	on	on	ADP
mkg-1066	17	113	oral	oral	ADJ
mkg-1066	17	114	candidiasis	candidiasis	NOUN
mkg-1066	17	115	in	in	ADP
mkg-1066	17	116	hiv	hiv	PROPN
mkg-1066	17	117	-	-	PUNCT
mkg-1066	17	118	infected	infect	VERB
mkg-1066	17	119	and	and	CCONJ
mkg-1066	17	120	aids	aid	NOUN
mkg-1066	17	121	patients	patient	NOUN
mkg-1066	17	122	.	.	PUNCT
mkg-1066	18	1	hiv	hiv	PROPN
mkg-1066	18	2	/	/	SYM
mkg-1066	18	3	aids	aid	NOUN
mkg-1066	18	4	and	and	CCONJ
mkg-1066	18	5	oral	oral	ADJ
mkg-1066	18	6	candidiasis	candidiasis	NOUN
mkg-1066	18	7	from	from	ADP
mkg-1066	18	8	the	the	DET
mkg-1066	18	9	earliest	early	ADJ
mkg-1066	18	10	periods	period	NOUN
mkg-1066	18	11	of	of	ADP
mkg-1066	18	12	aids	aid	NOUN
mkg-1066	18	13	epidemic	epidemic	NOUN
mkg-1066	18	14	,	,	PUNCT
mkg-1066	18	15	oral	oral	ADJ
mkg-1066	18	16	candidiasis	candidiasis	NOUN
mkg-1066	18	17	was	be	AUX
mkg-1066	18	18	recognized	recognize	VERB
mkg-1066	18	19	as	as	ADP
mkg-1066	18	20	an	an	DET
mkg-1066	18	21	important	important	ADJ
mkg-1066	18	22	sign	sign	NOUN
mkg-1066	18	23	of	of	ADP
mkg-1066	18	24	disease	disease	NOUN
mkg-1066	18	25	process	process	NOUN
mkg-1066	18	26	and	and	CCONJ
mkg-1066	18	27	its	its	PRON
mkg-1066	18	28	progression	progression	NOUN
mkg-1066	18	29	.	.	PUNCT
mkg-1066	19	1	the	the	DET
mkg-1066	19	2	frequency	frequency	NOUN
mkg-1066	19	3	of	of	ADP
mkg-1066	19	4	candida	candida	PROPN
mkg-1066	19	5	isolation	isolation	NOUN
mkg-1066	19	6	and	and	CCONJ
mkg-1066	19	7	clinical	clinical	ADJ
mkg-1066	19	8	signs	sign	NOUN
mkg-1066	19	9	of	of	ADP
mkg-1066	19	10	oral	oral	ADJ
mkg-1066	19	11	candidiasis	candidiasis	NOUN
mkg-1066	19	12	increases	increase	VERB
mkg-1066	19	13	with	with	ADP
mkg-1066	19	14	advancing	advance	VERB
mkg-1066	19	15	hiv	hiv	PROPN
mkg-1066	19	16	infection.10,11	infection.10,11	NOUN
mkg-1066	19	17	the	the	DET
mkg-1066	19	18	prevalence	prevalence	NOUN
mkg-1066	19	19	ranges	range	VERB
mkg-1066	19	20	between	between	ADP
mkg-1066	19	21	30	30	NUM
mkg-1066	19	22	and	and	CCONJ
mkg-1066	19	23	60	60	NUM
mkg-1066	19	24	%	%	NOUN
mkg-1066	19	25	among	among	ADP
mkg-1066	19	26	hiv	hiv	PROPN
mkg-1066	19	27	-	-	PUNCT
mkg-1066	19	28	infected	infect	VERB
mkg-1066	19	29	subjects	subject	NOUN
mkg-1066	19	30	and	and	CCONJ
mkg-1066	19	31	reaches	reach	VERB
mkg-1066	19	32	90	90	NUM
mkg-1066	19	33	%	%	NOUN
mkg-1066	19	34	in	in	ADP
mkg-1066	19	35	patients	patient	NOUN
mkg-1066	19	36	with	with	ADP
mkg-1066	19	37	aids.12,13	aids.12,13	ADJ
mkg-1066	19	38	oral	oral	ADJ
mkg-1066	19	39	candidiasis	candidiasis	NOUN
mkg-1066	19	40	in	in	ADP
mkg-1066	19	41	hiv	hiv	PROPN
mkg-1066	19	42	-	-	PUNCT
mkg-1066	19	43	infected	infect	VERB
mkg-1066	19	44	and	and	CCONJ
mkg-1066	19	45	aids	aid	NOUN
mkg-1066	19	46	patients	patient	NOUN
mkg-1066	19	47	may	may	AUX
mkg-1066	19	48	present	present	VERB
mkg-1066	19	49	as	as	ADP
mkg-1066	19	50	pseudomembranous	pseudomembranous	ADJ
mkg-1066	19	51	,	,	PUNCT
mkg-1066	19	52	erythematous	erythematous	ADJ
mkg-1066	19	53	,	,	PUNCT
mkg-1066	19	54	hyperplastic	hyperplastic	ADJ
mkg-1066	19	55	and	and	CCONJ
mkg-1066	19	56	angular	angular	ADJ
mkg-1066	19	57	cheilitis	cheilitis	NOUN
mkg-1066	19	58	variants.10,11,12	variants.10,11,12	VERB
mkg-1066	19	59	the	the	DET
mkg-1066	19	60	presence	presence	NOUN
mkg-1066	19	61	of	of	ADP
mkg-1066	19	62	oral	oral	ADJ
mkg-1066	19	63	candidiasis	candidiasis	NOUN
mkg-1066	19	64	in	in	ADP
mkg-1066	19	65	hiv	hiv	PROPN
mkg-1066	19	66	-	-	PUNCT
mkg-1066	19	67	infected	infect	VERB
mkg-1066	19	68	and	and	CCONJ
mkg-1066	19	69	aids	aid	NOUN
mkg-1066	19	70	patients	patient	NOUN
mkg-1066	19	71	was	be	AUX
mkg-1066	19	72	associated	associate	VERB
mkg-1066	19	73	with	with	ADP
mkg-1066	19	74	a	a	DET
mkg-1066	19	75	number	number	NOUN
mkg-1066	19	76	factors	factor	NOUN
mkg-1066	19	77	including	include	VERB
mkg-1066	19	78	low	low	ADJ
mkg-1066	19	79	cd4	cd4	PROPN
mkg-1066	19	80	counts	count	NOUN
mkg-1066	19	81	,	,	PUNCT
mkg-1066	19	82	increased	increase	VERB
mkg-1066	19	83	viral	viral	ADJ
mkg-1066	19	84	load	load	NOUN
mkg-1066	19	85	,	,	PUNCT
mkg-1066	19	86	xerostomia	xerostomia	NOUN
mkg-1066	19	87	,	,	PUNCT
mkg-1066	19	88	age	age	NOUN
mkg-1066	19	89	and	and	CCONJ
mkg-1066	19	90	secretory	secretory	ADJ
mkg-1066	19	91	aspartyl	aspartyl	NOUN
mkg-1066	19	92	proteinase	proteinase	NOUN
mkg-1066	19	93	(	(	PUNCT
mkg-1066	19	94	sap	sap	PROPN
mkg-1066	19	95	)	)	PUNCT
mkg-1066	19	96	,	,	PUNCT
mkg-1066	19	97	extracellular	extracellular	ADJ
mkg-1066	19	98	hydrolytic	hydrolytic	ADJ
mkg-1066	19	99	enzyme	enzyme	NOUN
mkg-1066	19	100	was	be	AUX
mkg-1066	19	101	product	product	NOUN
mkg-1066	19	102	by	by	ADP
mkg-1066	19	103	candida.7,10,13,14	candida.7,10,13,14	NOUN
mkg-1066	19	104	oral	oral	ADJ
mkg-1066	19	105	candidiasis	candidiasis	NOUN
mkg-1066	19	106	occurs	occur	VERB
mkg-1066	19	107	more	more	ADV
mkg-1066	19	108	frequently	frequently	ADV
mkg-1066	19	109	in	in	ADP
mkg-1066	19	110	hivinfected	hivinfected	ADJ
mkg-1066	19	111	patients	patient	NOUN
mkg-1066	19	112	with	with	ADP
mkg-1066	19	113	low	low	ADJ
mkg-1066	19	114	cd4	cd4	PROPN
mkg-1066	19	115	counts	count	NOUN
mkg-1066	19	116	.	.	PUNCT
mkg-1066	20	1	imam	imam	PROPN
mkg-1066	20	2	et	et	PROPN
mkg-1066	20	3	al	al	PROPN
mkg-1066	20	4	found	find	VERB
mkg-1066	20	5	a	a	DET
mkg-1066	20	6	statistically	statistically	ADV
mkg-1066	20	7	significant	significant	ADJ
mkg-1066	20	8	increase	increase	NOUN
mkg-1066	20	9	in	in	ADP
mkg-1066	20	10	the	the	DET
mkg-1066	20	11	frequency	frequency	NOUN
mkg-1066	20	12	of	of	ADP
mkg-1066	20	13	hivrelated	hivrelated	ADJ
mkg-1066	20	14	oral	oral	ADJ
mkg-1066	20	15	candidiaisis	candidiaisis	NOUN
mkg-1066	20	16	in	in	ADP
mkg-1066	20	17	patients	patient	NOUN
mkg-1066	20	18	with	with	ADP
mkg-1066	20	19	cd4	cd4	PROPN
mkg-1066	20	20	counts	count	NOUN
mkg-1066	20	21	of	of	ADP
mkg-1066	20	22	less	less	ADJ
mkg-1066	20	23	than	than	ADP
mkg-1066	20	24	300	300	NUM
mkg-1066	20	25	cells	cell	NOUN
mkg-1066	20	26	/	/	SYM
mkg-1066	20	27	mm3.7	mm3.7	NOUN
mkg-1066	20	28	this	this	DET
mkg-1066	20	29	condition	condition	NOUN
mkg-1066	20	30	made	make	VERB
mkg-1066	20	31	candida	candida	PROPN
mkg-1066	20	32	,	,	PUNCT
mkg-1066	20	33	�	�	X
mkg-1066	20	34	7hasibuan	7hasibuan	NUM
mkg-1066	20	35	:	:	PUNCT
mkg-1066	20	36	effect	effect	NOUN
mkg-1066	20	37	of	of	ADP
mkg-1066	20	38	combination	combination	NOUN
mkg-1066	20	39	antiretroviral	antiretroviral	ADJ
mkg-1066	20	40	therapi	therapi	NOUN
mkg-1066	20	41	normally	normally	ADV
mkg-1066	20	42	flora	flora	VERB
mkg-1066	20	43	normal	normal	ADJ
mkg-1066	20	44	of	of	ADP
mkg-1066	20	45	oral	oral	ADJ
mkg-1066	20	46	cavity	cavity	NOUN
mkg-1066	20	47	was	be	AUX
mkg-1066	20	48	easy	easy	ADJ
mkg-1066	20	49	develop	develop	VERB
mkg-1066	20	50	and	and	CCONJ
mkg-1066	20	51	inadequate	inadequate	ADJ
mkg-1066	20	52	immune	immune	ADJ
mkg-1066	20	53	system	system	NOUN
mkg-1066	20	54	will	will	AUX
mkg-1066	20	55	made	make	VERB
mkg-1066	20	56	resistance	resistance	NOUN
mkg-1066	20	57	to	to	ADP
mkg-1066	20	58	candida	candida	PROPN
mkg-1066	20	59	decreased	decrease	VERB
mkg-1066	20	60	and	and	CCONJ
mkg-1066	20	61	facilitated	facilitate	VERB
mkg-1066	20	62	candida	candida	NOUN
mkg-1066	20	63	to	to	ADP
mkg-1066	20	64	invasion	invasion	NOUN
mkg-1066	20	65	of	of	ADP
mkg-1066	20	66	tissue.10	tissue.10	NOUN
mkg-1066	20	67	viral	viral	ADJ
mkg-1066	20	68	load	load	NOUN
mkg-1066	20	69	has	have	VERB
mkg-1066	20	70	important	important	ADJ
mkg-1066	20	71	role	role	NOUN
mkg-1066	20	72	in	in	ADP
mkg-1066	20	73	the	the	DET
mkg-1066	20	74	pathogenesis	pathogenesis	NOUN
mkg-1066	20	75	of	of	ADP
mkg-1066	20	76	oral	oral	ADJ
mkg-1066	20	77	candidiasis	candidiasis	NOUN
mkg-1066	20	78	in	in	ADP
mkg-1066	20	79	the	the	DET
mkg-1066	20	80	hiv	hiv	PROPN
mkg-1066	20	81	-	-	PUNCT
mkg-1066	20	82	infected	infect	VERB
mkg-1066	20	83	and	and	CCONJ
mkg-1066	20	84	aids	aid	NOUN
mkg-1066	20	85	patients	patient	NOUN
mkg-1066	20	86	.	.	PUNCT
mkg-1066	21	1	several	several	ADJ
mkg-1066	21	2	investigations	investigation	NOUN
mkg-1066	21	3	had	have	AUX
mkg-1066	21	4	shown	show	VERB
mkg-1066	21	5	that	that	SCONJ
mkg-1066	21	6	associated	associate	VERB
mkg-1066	21	7	of	of	ADP
mkg-1066	21	8	oral	oral	ADJ
mkg-1066	21	9	lesions	lesion	NOUN
mkg-1066	21	10	with	with	ADP
mkg-1066	21	11	elevated	elevated	ADJ
mkg-1066	21	12	viral	viral	ADJ
mkg-1066	21	13	load	load	NOUN
mkg-1066	21	14	levels	level	NOUN
mkg-1066	21	15	because	because	SCONJ
mkg-1066	21	16	immune	immune	ADJ
mkg-1066	21	17	system	system	NOUN
mkg-1066	21	18	disorders.15	disorders.15	PROPN
mkg-1066	21	19	migliorati	migliorati	PROPN
mkg-1066	21	20	et	et	PROPN
mkg-1066	21	21	al.11	al.11	PROPN
mkg-1066	21	22	demonstrated	demonstrate	VERB
mkg-1066	21	23	that	that	SCONJ
mkg-1066	21	24	the	the	DET
mkg-1066	21	25	risk	risk	NOUN
mkg-1066	21	26	of	of	ADP
mkg-1066	21	27	developing	develop	VERB
mkg-1066	21	28	oral	oral	ADJ
mkg-1066	21	29	candidiasis	candidiasis	NOUN
mkg-1066	21	30	in	in	ADP
mkg-1066	21	31	hiv	hiv	PROPN
mkg-1066	21	32	patients	patient	NOUN
mkg-1066	21	33	is	be	AUX
mkg-1066	21	34	higher	high	ADJ
mkg-1066	21	35	when	when	SCONJ
mkg-1066	21	36	the	the	DET
mkg-1066	21	37	viral	viral	ADJ
mkg-1066	21	38	load	load	NOUN
mkg-1066	21	39	is	be	AUX
mkg-1066	21	40	above	above	ADP
mkg-1066	21	41	3,000	3,000	NUM
mkg-1066	21	42	copies	copy	NOUN
mkg-1066	21	43	/	/	SYM
mkg-1066	21	44	ml	ml	NOUN
mkg-1066	21	45	.	.	PUNCT
mkg-1066	22	1	there	there	PRON
mkg-1066	22	2	are	be	VERB
mkg-1066	22	3	reports	report	NOUN
mkg-1066	22	4	that	that	PRON
mkg-1066	22	5	salivary	salivary	VERB
mkg-1066	22	6	anticandidal	anticandidal	ADJ
mkg-1066	22	7	activities	activity	NOUN
mkg-1066	22	8	are	be	AUX
mkg-1066	22	9	compromised	compromise	VERB
mkg-1066	22	10	in	in	ADP
mkg-1066	22	11	aids	aid	NOUN
mkg-1066	22	12	patients	patient	NOUN
mkg-1066	22	13	and	and	CCONJ
mkg-1066	22	14	give	give	VERB
mkg-1066	22	15	contribution	contribution	NOUN
mkg-1066	22	16	to	to	ADP
mkg-1066	22	17	increased	increase	VERB
mkg-1066	22	18	incidence	incidence	NOUN
mkg-1066	22	19	of	of	ADP
mkg-1066	22	20	candida	candida	PROPN
mkg-1066	22	21	oral	oral	ADJ
mkg-1066	22	22	infection	infection	NOUN
mkg-1066	22	23	.	.	PUNCT
mkg-1066	23	1	a	a	DET
mkg-1066	23	2	pilot	pilot	NOUN
mkg-1066	23	3	study	study	NOUN
mkg-1066	23	4	of	of	ADP
mkg-1066	23	5	12	12	NUM
mkg-1066	23	6	aids	aid	NOUN
mkg-1066	23	7	patients	patient	NOUN
mkg-1066	23	8	showed	show	VERB
mkg-1066	23	9	that	that	SCONJ
mkg-1066	23	10	salivary	salivary	ADJ
mkg-1066	23	11	anticandidal	anticandidal	ADJ
mkg-1066	23	12	activity	activity	NOUN
mkg-1066	23	13	was	be	AUX
mkg-1066	23	14	decreased	decrease	VERB
mkg-1066	23	15	as	as	SCONJ
mkg-1066	23	16	compared	compare	VERB
mkg-1066	23	17	with	with	ADP
mkg-1066	23	18	healthy	healthy	ADJ
mkg-1066	23	19	controls	control	NOUN
mkg-1066	23	20	.	.	PUNCT
mkg-1066	24	1	this	this	DET
mkg-1066	24	2	decrease	decrease	NOUN
mkg-1066	24	3	in	in	ADP
mkg-1066	24	4	salivary	salivary	ADJ
mkg-1066	24	5	anticandidal	anticandidal	ADJ
mkg-1066	24	6	activity	activity	NOUN
mkg-1066	24	7	in	in	ADP
mkg-1066	24	8	aids	aid	NOUN
mkg-1066	24	9	patients	patient	NOUN
mkg-1066	24	10	has	have	AUX
mkg-1066	24	11	been	be	AUX
mkg-1066	24	12	attributed	attribute	VERB
mkg-1066	24	13	to	to	ADP
mkg-1066	24	14	a	a	DET
mkg-1066	24	15	decrease	decrease	NOUN
mkg-1066	24	16	in	in	ADP
mkg-1066	24	17	the	the	DET
mkg-1066	24	18	concentration	concentration	NOUN
mkg-1066	24	19	of	of	ADP
mkg-1066	24	20	salivary	salivary	ADJ
mkg-1066	24	21	histatines	histatine	NOUN
mkg-1066	24	22	and/or	and/or	CCONJ
mkg-1066	24	23	to	to	ADP
mkg-1066	24	24	dysfunction	dysfunction	NOUN
mkg-1066	24	25	of	of	ADP
mkg-1066	24	26	these	these	DET
mkg-1066	24	27	proteins.13	proteins.13	PROPN
mkg-1066	24	28	histatine	histatine	PROPN
mkg-1066	24	29	are	be	AUX
mkg-1066	24	30	a	a	DET
mkg-1066	24	31	family	family	NOUN
mkg-1066	24	32	of	of	ADP
mkg-1066	24	33	histidine	histidine	NOUN
mkg-1066	24	34	-	-	PUNCT
mkg-1066	24	35	rich	rich	ADJ
mkg-1066	24	36	polypeptides	polypeptide	NOUN
mkg-1066	24	37	and	and	CCONJ
mkg-1066	24	38	are	be	AUX
mkg-1066	24	39	the	the	DET
mkg-1066	24	40	major	major	ADJ
mkg-1066	24	41	antifungal	antifungal	ADJ
mkg-1066	24	42	proteins	protein	NOUN
mkg-1066	24	43	present	present	ADJ
mkg-1066	24	44	in	in	ADP
mkg-1066	24	45	human	human	ADJ
mkg-1066	24	46	saliva	saliva	NOUN
mkg-1066	24	47	.	.	PUNCT
mkg-1066	25	1	in	in	ADP
mkg-1066	25	2	addition	addition	NOUN
mkg-1066	25	3	,	,	PUNCT
mkg-1066	25	4	many	many	ADJ
mkg-1066	25	5	of	of	ADP
mkg-1066	25	6	the	the	DET
mkg-1066	25	7	specific	specific	ADJ
mkg-1066	25	8	proteins	protein	NOUN
mkg-1066	25	9	secreted	secrete	VERB
mkg-1066	25	10	by	by	ADP
mkg-1066	25	11	the	the	DET
mkg-1066	25	12	salivary	salivary	ADJ
mkg-1066	25	13	glands	gland	NOUN
mkg-1066	25	14	have	have	AUX
mkg-1066	25	15	antifungal	antifungal	ADJ
mkg-1066	25	16	activities	activity	NOUN
mkg-1066	25	17	like	like	ADP
mkg-1066	25	18	ig	ig	PRON
mkg-1066	25	19	a	a	PRON
mkg-1066	25	20	,	,	PUNCT
mkg-1066	25	21	lactoferin	lactoferin	NOUN
mkg-1066	25	22	and	and	CCONJ
mkg-1066	25	23	lysozyme	lysozyme	NOUN
mkg-1066	25	24	were	be	AUX
mkg-1066	25	25	decreased	decrease	VERB
mkg-1066	25	26	too.13	too.13	PROPN
mkg-1066	25	27	neutropenia	neutropenia	PROPN
mkg-1066	25	28	is	be	AUX
mkg-1066	25	29	a	a	DET
mkg-1066	25	30	frequent	frequent	ADJ
mkg-1066	25	31	hematological	hematological	ADJ
mkg-1066	25	32	complication	complication	NOUN
mkg-1066	25	33	in	in	ADP
mkg-1066	25	34	hiv	hiv	PROPN
mkg-1066	25	35	infection	infection	NOUN
mkg-1066	25	36	,	,	PUNCT
mkg-1066	25	37	detected	detect	VERB
mkg-1066	25	38	in	in	ADP
mkg-1066	25	39	20	20	NUM
mkg-1066	25	40	%	%	NOUN
mkg-1066	25	41	to	to	PART
mkg-1066	25	42	50	50	NUM
mkg-1066	25	43	%	%	NOUN
mkg-1066	25	44	of	of	ADP
mkg-1066	25	45	symptomatic	symptomatic	ADJ
mkg-1066	25	46	patients	patient	NOUN
mkg-1066	25	47	,	,	PUNCT
mkg-1066	25	48	it	it	PRON
mkg-1066	25	49	is	be	AUX
mkg-1066	25	50	usually	usually	ADV
mkg-1066	25	51	accompanied	accompany	VERB
mkg-1066	25	52	by	by	ADP
mkg-1066	25	53	functional	functional	ADJ
mkg-1066	25	54	alterations	alteration	NOUN
mkg-1066	25	55	of	of	ADP
mkg-1066	25	56	neutrophils	neutrophil	NOUN
mkg-1066	25	57	.	.	PUNCT
mkg-1066	26	1	as	as	SCONJ
mkg-1066	26	2	we	we	PRON
mkg-1066	26	3	know	know	VERB
mkg-1066	26	4	,	,	PUNCT
mkg-1066	26	5	neutrophils	neutrophil	NOUN
mkg-1066	26	6	play	play	VERB
mkg-1066	26	7	a	a	DET
mkg-1066	26	8	pivotal	pivotal	ADJ
mkg-1066	26	9	role	role	NOUN
mkg-1066	26	10	in	in	ADP
mkg-1066	26	11	the	the	DET
mkg-1066	26	12	defense	defense	NOUN
mkg-1066	26	13	mechanism	mechanism	NOUN
mkg-1066	26	14	against	against	ADP
mkg-1066	26	15	candida	candida	PROPN
mkg-1066	26	16	.	.	PUNCT
mkg-1066	27	1	dios	dios	PROPN
mkg-1066	27	2	et	et	PROPN
mkg-1066	27	3	al.16	al.16	PROPN
mkg-1066	27	4	had	have	AUX
mkg-1066	27	5	shown	show	VERB
mkg-1066	27	6	in	in	ADP
mkg-1066	27	7	their	their	PRON
mkg-1066	27	8	study	study	NOUN
mkg-1066	27	9	,	,	PUNCT
mkg-1066	27	10	6	6	NUM
mkg-1066	27	11	neutropenic	neutropenic	ADJ
mkg-1066	27	12	patients	patient	NOUN
mkg-1066	27	13	with	with	ADP
mkg-1066	27	14	aids	aid	NOUN
mkg-1066	27	15	and	and	CCONJ
mkg-1066	27	16	neutrophils	neutrophil	NOUN
mkg-1066	27	17	counts	count	VERB
mkg-1066	27	18	below	below	ADP
mkg-1066	27	19	1	1	NUM
mkg-1066	27	20	×	×	NOUN
mkg-1066	27	21	109	109	NUM
mkg-1066	27	22	per	per	ADP
mkg-1066	27	23	liter	liter	NOUN
mkg-1066	27	24	have	have	VERB
mkg-1066	27	25	greatest	great	ADJ
mkg-1066	27	26	number	number	NOUN
mkg-1066	27	27	of	of	ADP
mkg-1066	27	28	episodes	episode	NOUN
mkg-1066	27	29	of	of	ADP
mkg-1066	27	30	oral	oral	ADJ
mkg-1066	27	31	candidiasis	candidiasis	NOUN
mkg-1066	27	32	.	.	PUNCT
mkg-1066	28	1	secretory	secretory	ADJ
mkg-1066	28	2	aspartyl	aspartyl	PROPN
mkg-1066	28	3	proteinase	proteinase	PROPN
mkg-1066	28	4	(	(	PUNCT
mkg-1066	28	5	sap	sap	PROPN
mkg-1066	28	6	)	)	PUNCT
mkg-1066	28	7	have	have	AUX
mkg-1066	28	8	been	be	AUX
mkg-1066	28	9	the	the	DET
mkg-1066	28	10	most	most	ADV
mkg-1066	28	11	comprehensively	comprehensively	ADV
mkg-1066	28	12	studied	study	VERB
mkg-1066	28	13	has	have	VERB
mkg-1066	28	14	an	an	DET
mkg-1066	28	15	important	important	ADJ
mkg-1066	28	16	key	key	NOUN
mkg-1066	28	17	in	in	ADP
mkg-1066	28	18	the	the	DET
mkg-1066	28	19	presence	presence	NOUN
mkg-1066	28	20	of	of	ADP
mkg-1066	28	21	oral	oral	ADJ
mkg-1066	28	22	candidiasis	candidiasis	NOUN
mkg-1066	28	23	.	.	PUNCT
mkg-1066	29	1	sap	sap	PROPN
mkg-1066	29	2	is	be	AUX
mkg-1066	29	3	an	an	DET
mkg-1066	29	4	extracellular	extracellular	ADJ
mkg-1066	29	5	hydrolytic	hydrolytic	ADJ
mkg-1066	29	6	enzymes	enzyme	NOUN
mkg-1066	29	7	produced	produce	VERB
mkg-1066	29	8	by	by	ADP
mkg-1066	29	9	candida	candida	PROPN
mkg-1066	29	10	albicans.17	albicans.17	PROPN
mkg-1066	29	11	one	one	NUM
mkg-1066	29	12	investigation	investigation	NOUN
mkg-1066	29	13	had	have	AUX
mkg-1066	29	14	reported	report	VERB
mkg-1066	29	15	a	a	DET
mkg-1066	29	16	comparable	comparable	ADJ
mkg-1066	29	17	increase	increase	NOUN
mkg-1066	29	18	in	in	ADP
mkg-1066	29	19	sap	sap	NOUN
mkg-1066	29	20	activity	activity	NOUN
mkg-1066	29	21	in	in	ADP
mkg-1066	29	22	candida	candida	NOUN
mkg-1066	29	23	albicans	albican	NOUN
mkg-1066	29	24	strains	strain	NOUN
mkg-1066	29	25	isolated	isolate	VERB
mkg-1066	29	26	from	from	ADP
mkg-1066	29	27	the	the	DET
mkg-1066	29	28	oral	oral	ADJ
mkg-1066	29	29	cavities	cavity	NOUN
mkg-1066	29	30	of	of	ADP
mkg-1066	29	31	44	44	NUM
mkg-1066	29	32	hiv	hiv	NOUN
mkg-1066	29	33	-	-	PUNCT
mkg-1066	29	34	positive	positive	ADJ
mkg-1066	29	35	patients	patient	NOUN
mkg-1066	29	36	with	with	ADP
mkg-1066	29	37	oral	oral	ADJ
mkg-1066	29	38	candidiasis	candidiasis	NOUN
mkg-1066	29	39	compared	compare	VERB
mkg-1066	29	40	with	with	ADP
mkg-1066	29	41	that	that	PRON
mkg-1066	29	42	in	in	ADP
mkg-1066	29	43	30	30	NUM
mkg-1066	29	44	hiv	hiv	NOUN
mkg-1066	29	45	-	-	PUNCT
mkg-1066	29	46	negative	negative	ADJ
mkg-1066	29	47	candida	candida	NOUN
mkg-1066	29	48	albicans	albican	NOUN
mkg-1066	29	49	carriers	carrier	NOUN
mkg-1066	29	50	.	.	PUNCT
mkg-1066	30	1	apparently	apparently	ADV
mkg-1066	30	2	,	,	PUNCT
mkg-1066	30	3	candida	candida	NOUN
mkg-1066	30	4	albicans	albican	VERB
mkg-1066	30	5	isolates	isolate	NOUN
mkg-1066	30	6	from	from	ADP
mkg-1066	30	7	hivpositive	hivpositive	ADJ
mkg-1066	30	8	subjects	subject	NOUN
mkg-1066	30	9	produced	produce	VERB
mkg-1066	30	10	significantly	significantly	ADV
mkg-1066	30	11	more	more	ADV
mkg-1066	30	12	proteinase	proteinase	NOUN
mkg-1066	30	13	than	than	SCONJ
mkg-1066	30	14	did	do	VERB
mkg-1066	30	15	isolates	isolate	NOUN
mkg-1066	30	16	from	from	ADP
mkg-1066	30	17	hiv	hiv	PROPN
mkg-1066	30	18	-	-	PUNCT
mkg-1066	30	19	negative	negative	ADJ
mkg-1066	30	20	individuals.17	individuals.17	ADJ
mkg-1066	30	21	antiretroviral	antiretroviral	ADJ
mkg-1066	30	22	therapy	therapy	NOUN
mkg-1066	30	23	for	for	ADP
mkg-1066	30	24	the	the	DET
mkg-1066	30	25	hiv	hiv	PROPN
mkg-1066	30	26	/	/	SYM
mkg-1066	30	27	aids	aids	PROPN
mkg-1066	30	28	patients	patient	NOUN
mkg-1066	30	29	until	until	ADP
mkg-1066	30	30	this	this	DET
mkg-1066	30	31	day	day	NOUN
mkg-1066	30	32	,	,	PUNCT
mkg-1066	30	33	there	there	PRON
mkg-1066	30	34	are	be	VERB
mkg-1066	30	35	three	three	NUM
mkg-1066	30	36	classes	class	NOUN
mkg-1066	30	37	of	of	ADP
mkg-1066	30	38	drugs	drug	NOUN
mkg-1066	30	39	that	that	PRON
mkg-1066	30	40	used	use	VERB
mkg-1066	30	41	treatment	treatment	NOUN
mkg-1066	30	42	hiv	hiv	NOUN
mkg-1066	30	43	-	-	PUNCT
mkg-1066	30	44	infected	infect	VERB
mkg-1066	30	45	patients	patient	NOUN
mkg-1066	30	46	.	.	PUNCT
mkg-1066	31	1	they	they	PRON
mkg-1066	31	2	are	be	AUX
mkg-1066	31	3	nucleoside	nucleoside	ADV
mkg-1066	31	4	reverse	reverse	ADJ
mkg-1066	31	5	transcriptase	transcriptase	NOUN
mkg-1066	31	6	inhibitor	inhibitor	NOUN
mkg-1066	31	7	(	(	PUNCT
mkg-1066	31	8	nrti	nrti	PROPN
mkg-1066	31	9	)	)	PUNCT
mkg-1066	31	10	,	,	PUNCT
mkg-1066	31	11	non	non	ADJ
mkg-1066	31	12	-	-	ADJ
mkg-1066	31	13	nucleoside	nucleoside	ADJ
mkg-1066	31	14	reverse	reverse	ADJ
mkg-1066	31	15	transcriptase	transcriptase	NOUN
mkg-1066	31	16	inhibitor	inhibitor	NOUN
mkg-1066	31	17	(	(	PUNCT
mkg-1066	31	18	nnrti	nnrti	NOUN
mkg-1066	31	19	)	)	PUNCT
mkg-1066	31	20	and	and	CCONJ
mkg-1066	31	21	protease	protease	NOUN
mkg-1066	31	22	inhibitor	inhibitor	NOUN
mkg-1066	31	23	(	(	PUNCT
mkg-1066	31	24	pi).4,18,19	pi).4,18,19	NOUN
mkg-1066	31	25	nucleoside	nucleoside	ADV
mkg-1066	31	26	reverse	reverse	ADJ
mkg-1066	31	27	transcriptase	transcriptase	NOUN
mkg-1066	31	28	inhibitor	inhibitor	NOUN
mkg-1066	31	29	(	(	PUNCT
mkg-1066	31	30	nrti	nrti	PROPN
mkg-1066	31	31	):	):	PUNCT
mkg-1066	31	32	nrti	nrti	PROPN
mkg-1066	31	33	was	be	AUX
mkg-1066	31	34	the	the	DET
mkg-1066	31	35	first	first	ADJ
mkg-1066	31	36	drugs	drug	NOUN
mkg-1066	31	37	made	make	VERB
mkg-1066	31	38	available	available	ADJ
mkg-1066	31	39	for	for	ADP
mkg-1066	31	40	the	the	DET
mkg-1066	31	41	treatment	treatment	NOUN
mkg-1066	31	42	of	of	ADP
mkg-1066	31	43	hiv	hiv	PROPN
mkg-1066	31	44	-	-	PUNCT
mkg-1066	31	45	infected	infect	VERB
mkg-1066	31	46	patients	patient	NOUN
mkg-1066	31	47	.	.	PUNCT
mkg-1066	32	1	the	the	DET
mkg-1066	32	2	reverse	reverse	ADJ
mkg-1066	32	3	transcriptase	transcriptase	NOUN
mkg-1066	32	4	inhibitor	inhibitor	NOUN
mkg-1066	32	5	is	be	AUX
mkg-1066	32	6	phosphorylated	phosphorylate	VERB
mkg-1066	32	7	in	in	ADP
mkg-1066	32	8	the	the	DET
mkg-1066	32	9	cell	cell	NOUN
mkg-1066	32	10	to	to	ADP
mkg-1066	32	11	the	the	DET
mkg-1066	32	12	tryphosphate	tryphosphate	NOUN
mkg-1066	32	13	,	,	PUNCT
mkg-1066	32	14	which	which	PRON
mkg-1066	32	15	inhibits	inhibit	VERB
mkg-1066	32	16	the	the	DET
mkg-1066	32	17	hiv	hiv	PROPN
mkg-1066	32	18	reverse	reverse	VERB
mkg-1066	32	19	transcriptase	transcriptase	NOUN
mkg-1066	32	20	and	and	CCONJ
mkg-1066	32	21	leads	lead	VERB
mkg-1066	32	22	to	to	ADP
mkg-1066	32	23	premature	premature	ADJ
mkg-1066	32	24	termination	termination	NOUN
mkg-1066	32	25	of	of	ADP
mkg-1066	32	26	the	the	DET
mkg-1066	32	27	hiv	hiv	PROPN
mkg-1066	32	28	dna	dna	PROPN
mkg-1066	32	29	chain	chain	NOUN
mkg-1066	32	30	.	.	PUNCT
mkg-1066	33	1	include	include	VERB
mkg-1066	33	2	in	in	ADP
mkg-1066	33	3	this	this	DET
mkg-1066	33	4	class	class	NOUN
mkg-1066	33	5	of	of	ADP
mkg-1066	33	6	dugs	dug	NOUN
mkg-1066	33	7	are	be	AUX
mkg-1066	33	8	zidovudine	zidovudine	PROPN
mkg-1066	33	9	(	(	PUNCT
mkg-1066	33	10	azt	azt	PROPN
mkg-1066	33	11	)	)	PUNCT
mkg-1066	33	12	,	,	PUNCT
mkg-1066	33	13	didanosine	didanosine	PROPN
mkg-1066	33	14	(	(	PUNCT
mkg-1066	33	15	ddi	ddi	PROPN
mkg-1066	33	16	)	)	PUNCT
mkg-1066	33	17	,	,	PUNCT
mkg-1066	33	18	zalcitabine	zalcitabine	PROPN
mkg-1066	33	19	(	(	PUNCT
mkg-1066	33	20	ddc	ddc	PROPN
mkg-1066	33	21	)	)	PUNCT
mkg-1066	33	22	,	,	PUNCT
mkg-1066	33	23	stavudine	stavudine	NOUN
mkg-1066	33	24	(	(	PUNCT
mkg-1066	33	25	d4	d4	PROPN
mkg-1066	33	26	t	t	PROPN
mkg-1066	33	27	)	)	PUNCT
mkg-1066	33	28	and	and	CCONJ
mkg-1066	33	29	lamivudine	lamivudine	NOUN
mkg-1066	33	30	(	(	PUNCT
mkg-1066	33	31	3tc).4,19	3tc).4,19	PROPN
mkg-1066	33	32	non	non	X
mkg-1066	33	33	nucleoside	nucleoside	ADV
mkg-1066	33	34	reverse	reverse	VERB
mkg-1066	33	35	transcriptase	transcriptase	NOUN
mkg-1066	33	36	inhibitor	inhibitor	NOUN
mkg-1066	33	37	(	(	PUNCT
mkg-1066	33	38	nrti	nrti	NOUN
mkg-1066	33	39	):	):	PUNCT
mkg-1066	33	40	non	non	X
mkg-1066	33	41	nucleoside	nucleoside	ADV
mkg-1066	33	42	reverse	reverse	ADJ
mkg-1066	33	43	transcriptase	transcriptase	NOUN
mkg-1066	33	44	inhibitor	inhibitor	NOUN
mkg-1066	33	45	(	(	PUNCT
mkg-1066	33	46	nrti	nrti	PROPN
mkg-1066	33	47	)	)	PUNCT
mkg-1066	33	48	are	be	AUX
mkg-1066	33	49	a	a	DET
mkg-1066	33	50	group	group	NOUN
mkg-1066	33	51	of	of	ADP
mkg-1066	33	52	structurally	structurally	ADV
mkg-1066	33	53	diverse	diverse	ADJ
mkg-1066	33	54	agents	agent	NOUN
mkg-1066	33	55	which	which	PRON
mkg-1066	33	56	bind	bind	VERB
mkg-1066	33	57	to	to	PART
mkg-1066	33	58	reverse	reverse	VERB
mkg-1066	33	59	transcriptase	transcriptase	NOUN
mkg-1066	33	60	at	at	ADP
mkg-1066	33	61	a	a	DET
mkg-1066	33	62	site	site	NOUN
mkg-1066	33	63	distant	distant	ADJ
mkg-1066	33	64	to	to	ADP
mkg-1066	33	65	the	the	DET
mkg-1066	33	66	active	active	ADJ
mkg-1066	33	67	site	site	NOUN
mkg-1066	33	68	resulting	result	VERB
mkg-1066	33	69	in	in	ADP
mkg-1066	33	70	conformational	conformational	ADJ
mkg-1066	33	71	changes	change	NOUN
mkg-1066	33	72	at	at	ADP
mkg-1066	33	73	the	the	DET
mkg-1066	33	74	active	active	ADJ
mkg-1066	33	75	and	and	CCONJ
mkg-1066	33	76	inhibition	inhibition	NOUN
mkg-1066	33	77	of	of	ADP
mkg-1066	33	78	enzyme	enzyme	NOUN
mkg-1066	33	79	activity	activity	NOUN
mkg-1066	33	80	.	.	PUNCT
mkg-1066	34	1	nrti	nrti	PROPN
mkg-1066	34	2	consists	consist	VERB
mkg-1066	34	3	of	of	ADP
mkg-1066	34	4	nevirapine	nevirapine	ADJ
mkg-1066	34	5	(	(	PUNCT
mkg-1066	34	6	nev	nev	NOUN
mkg-1066	34	7	)	)	PUNCT
mkg-1066	34	8	and	and	CCONJ
mkg-1066	34	9	delavirdine	delavirdine	NOUN
mkg-1066	34	10	(	(	PUNCT
mkg-1066	34	11	dlv).4,18,19	dlv).4,18,19	X
mkg-1066	34	12	protease	protease	NOUN
mkg-1066	34	13	inhibitor	inhibitor	NOUN
mkg-1066	34	14	(	(	PUNCT
mkg-1066	34	15	pi	pi	NOUN
mkg-1066	34	16	):	):	PUNCT
mkg-1066	34	17	protease	protease	NOUN
mkg-1066	34	18	inhibitor	inhibitor	NOUN
mkg-1066	34	19	(	(	PUNCT
mkg-1066	34	20	pi	pi	NOUN
mkg-1066	34	21	)	)	PUNCT
mkg-1066	34	22	was	be	AUX
mkg-1066	34	23	introduced	introduce	VERB
mkg-1066	34	24	in	in	ADP
mkg-1066	34	25	1996	1996	NUM
mkg-1066	34	26	and	and	CCONJ
mkg-1066	34	27	has	have	AUX
mkg-1066	34	28	different	different	ADV
mkg-1066	34	29	targeted	target	VERB
mkg-1066	34	30	with	with	ADP
mkg-1066	34	31	the	the	DET
mkg-1066	34	32	reverse	reverse	ADJ
mkg-1066	34	33	transcriptase	transcriptase	NOUN
mkg-1066	34	34	inhibitor.4,5	inhibitor.4,5	NOUN
mkg-1066	34	35	the	the	DET
mkg-1066	34	36	protease	protease	NOUN
mkg-1066	34	37	inhibitor	inhibitor	NOUN
mkg-1066	34	38	bind	bind	VERB
mkg-1066	34	39	competitively	competitively	ADV
mkg-1066	34	40	to	to	ADP
mkg-1066	34	41	the	the	DET
mkg-1066	34	42	substrate	substrate	NOUN
mkg-1066	34	43	site	site	NOUN
mkg-1066	34	44	of	of	ADP
mkg-1066	34	45	the	the	DET
mkg-1066	34	46	viral	viral	ADJ
mkg-1066	34	47	protease	protease	NOUN
mkg-1066	34	48	.	.	PUNCT
mkg-1066	35	1	this	this	DET
mkg-1066	35	2	enzyme	enzyme	NOUN
mkg-1066	35	3	is	be	AUX
mkg-1066	35	4	responsible	responsible	ADJ
mkg-1066	35	5	for	for	ADP
mkg-1066	35	6	the	the	DET
mkg-1066	35	7	post	post	ADJ
mkg-1066	35	8	-	-	ADJ
mkg-1066	35	9	translational	translational	ADJ
mkg-1066	35	10	processing	processing	NOUN
mkg-1066	35	11	and	and	CCONJ
mkg-1066	35	12	cleavage	cleavage	NOUN
mkg-1066	35	13	of	of	ADP
mkg-1066	35	14	a	a	DET
mkg-1066	35	15	large	large	ADJ
mkg-1066	35	16	structural	structural	ADJ
mkg-1066	35	17	core	core	NOUN
mkg-1066	35	18	protein	protein	NOUN
mkg-1066	35	19	during	during	ADP
mkg-1066	35	20	budding	bud	VERB
mkg-1066	35	21	from	from	ADP
mkg-1066	35	22	the	the	DET
mkg-1066	35	23	infected	infected	ADJ
mkg-1066	35	24	cell	cell	NOUN
mkg-1066	35	25	.	.	PUNCT
mkg-1066	36	1	inhibition	inhibition	NOUN
mkg-1066	36	2	results	result	NOUN
mkg-1066	36	3	in	in	ADP
mkg-1066	36	4	the	the	DET
mkg-1066	36	5	production	production	NOUN
mkg-1066	36	6	of	of	ADP
mkg-1066	36	7	immature	immature	ADJ
mkg-1066	36	8	virus	virus	NOUN
mkg-1066	36	9	particles.4,18,19	particles.4,18,19	NOUN
mkg-1066	36	10	protease	protease	NOUN
mkg-1066	36	11	inhibitor	inhibitor	NOUN
mkg-1066	36	12	consists	consist	VERB
mkg-1066	36	13	of	of	ADP
mkg-1066	36	14	saquinavir	saquinavir	NOUN
mkg-1066	36	15	(	(	PUNCT
mkg-1066	36	16	sqv	sqv	NOUN
mkg-1066	36	17	)	)	PUNCT
mkg-1066	36	18	,	,	PUNCT
mkg-1066	36	19	indinavir	indinavir	X
mkg-1066	36	20	(	(	PUNCT
mkg-1066	36	21	idv	idv	PROPN
mkg-1066	36	22	)	)	PUNCT
mkg-1066	36	23	,	,	PUNCT
mkg-1066	36	24	ritonavir	ritonavir	PROPN
mkg-1066	36	25	(	(	PUNCT
mkg-1066	36	26	rtv	rtv	PROPN
mkg-1066	36	27	)	)	PUNCT
mkg-1066	36	28	and	and	CCONJ
mkg-1066	36	29	amprenavir.19,20	amprenavir.19,20	NOUN
mkg-1066	36	30	in	in	ADP
mkg-1066	36	31	the	the	DET
mkg-1066	36	32	mid-1990s	mid-1990	NOUN
mkg-1066	36	33	,	,	PUNCT
mkg-1066	36	34	were	be	AUX
mkg-1066	36	35	introduced	introduce	VERB
mkg-1066	36	36	combination	combination	NOUN
mkg-1066	36	37	antiretroviral	antiretroviral	ADJ
mkg-1066	36	38	therapy	therapy	NOUN
mkg-1066	36	39	,	,	PUNCT
mkg-1066	36	40	so	so	ADV
mkg-1066	36	41	called	call	VERB
mkg-1066	36	42	highly	highly	ADV
mkg-1066	36	43	active	active	ADJ
mkg-1066	36	44	antiretroviral	antiretroviral	ADJ
mkg-1066	36	45	therapy	therapy	NOUN
mkg-1066	36	46	(	(	PUNCT
mkg-1066	36	47	haart	haart	PROPN
mkg-1066	36	48	)	)	PUNCT
mkg-1066	36	49	as	as	ADP
mkg-1066	36	50	a	a	DET
mkg-1066	36	51	standard	standard	ADJ
mkg-1066	36	52	treatment	treatment	NOUN
mkg-1066	36	53	for	for	ADP
mkg-1066	36	54	hivinfected	hivinfecte	VERB
mkg-1066	36	55	and	and	CCONJ
mkg-1066	36	56	aids	aid	NOUN
mkg-1066	36	57	patients.3	patients.3	VERB
mkg-1066	36	58	these	these	DET
mkg-1066	36	59	therapies	therapy	NOUN
mkg-1066	36	60	consists	consist	VERB
mkg-1066	36	61	of	of	ADP
mkg-1066	36	62	a	a	DET
mkg-1066	36	63	combination	combination	NOUN
mkg-1066	36	64	of	of	ADP
mkg-1066	36	65	at	at	ADV
mkg-1066	36	66	least	least	ADV
mkg-1066	36	67	3	3	NUM
mkg-1066	36	68	antiviral	antiviral	PROPN
mkg-1066	36	69	drugs2	drugs2	PROPN
mkg-1066	36	70	nrti	nrti	PROPN
mkg-1066	36	71	with	with	ADP
mkg-1066	36	72	either	either	CCONJ
mkg-1066	36	73	a	a	DET
mkg-1066	36	74	protease	protease	NOUN
mkg-1066	36	75	inhibitor	inhibitor	NOUN
mkg-1066	36	76	or	or	CCONJ
mkg-1066	36	77	an	an	DET
mkg-1066	36	78	nnrti.3,5,18	nnrti.3,5,18	NOUN
mkg-1066	36	79	the	the	DET
mkg-1066	36	80	aim	aim	NOUN
mkg-1066	36	81	of	of	ADP
mkg-1066	36	82	this	this	DET
mkg-1066	36	83	treatment	treatment	NOUN
mkg-1066	36	84	is	be	AUX
mkg-1066	36	85	to	to	PART
mkg-1066	36	86	reduce	reduce	VERB
mkg-1066	36	87	the	the	DET
mkg-1066	36	88	plasma	plasma	NOUN
mkg-1066	36	89	viral	viral	ADJ
mkg-1066	36	90	load	load	NOUN
mkg-1066	36	91	as	as	ADV
mkg-1066	36	92	much	much	ADV
mkg-1066	36	93	as	as	ADP
mkg-1066	36	94	possible	possible	ADJ
mkg-1066	36	95	and	and	CCONJ
mkg-1066	36	96	for	for	ADP
mkg-1066	36	97	as	as	ADV
mkg-1066	36	98	long	long	ADV
mkg-1066	36	99	as	as	ADP
mkg-1066	36	100	possible	possible	ADJ
mkg-1066	36	101	by	by	ADP
mkg-1066	36	102	attacking	attack	VERB
mkg-1066	36	103	the	the	DET
mkg-1066	36	104	virus	virus	NOUN
mkg-1066	36	105	at	at	ADP
mkg-1066	36	106	different	different	ADJ
mkg-1066	36	107	stages	stage	NOUN
mkg-1066	36	108	of	of	ADP
mkg-1066	36	109	its	its	PRON
mkg-1066	36	110	replication	replication	NOUN
mkg-1066	36	111	cycle	cycle	NOUN
mkg-1066	36	112	(	(	PUNCT
mkg-1066	36	113	figure	figure	NOUN
mkg-1066	36	114	1	1	NUM
mkg-1066	36	115	)	)	PUNCT
mkg-1066	36	116	,	,	PUNCT
mkg-1066	36	117	inhibiting	inhibit	VERB
mkg-1066	36	118	the	the	DET
mkg-1066	36	119	multiplication	multiplication	NOUN
mkg-1066	36	120	rate	rate	NOUN
mkg-1066	36	121	of	of	ADP
mkg-1066	36	122	the	the	DET
mkg-1066	36	123	virus	virus	NOUN
mkg-1066	36	124	and	and	CCONJ
mkg-1066	36	125	preventing	prevent	VERB
mkg-1066	36	126	the	the	DET
mkg-1066	36	127	development	development	NOUN
mkg-1066	36	128	of	of	ADP
mkg-1066	36	129	drug	drug	NOUN
mkg-1066	36	130	resistance.3	resistance.3	PROPN
mkg-1066	36	131	figure	figure	NOUN
mkg-1066	36	132	1	1	NUM
mkg-1066	36	133	.	.	PUNCT
mkg-1066	36	134	targets	target	NOUN
mkg-1066	36	135	for	for	ADP
mkg-1066	36	136	antiretroviral	antiretroviral	ADJ
mkg-1066	36	137	therapy.4	therapy.4	NOUN
mkg-1066	36	138	thus	thus	ADV
mkg-1066	36	139	,	,	PUNCT
mkg-1066	36	140	haart	haart	PROPN
mkg-1066	36	141	decreases	decrease	VERB
mkg-1066	36	142	hiv	hiv	PROPN
mkg-1066	36	143	viral	viral	ADJ
mkg-1066	36	144	load	load	NOUN
mkg-1066	36	145	and	and	CCONJ
mkg-1066	36	146	leads	lead	VERB
mkg-1066	36	147	to	to	ADP
mkg-1066	36	148	the	the	DET
mkg-1066	36	149	increase	increase	NOUN
mkg-1066	36	150	of	of	ADP
mkg-1066	36	151	cd4	cd4	PROPN
mkg-1066	36	152	lymphocytes	lymphocyte	NOUN
mkg-1066	36	153	counts	count	NOUN
mkg-1066	36	154	,	,	PUNCT
mkg-1066	36	155	causing	cause	VERB
mkg-1066	36	156	an	an	DET
mkg-1066	36	157	improvement	improvement	NOUN
mkg-1066	36	158	of	of	ADP
mkg-1066	36	159	immunity	immunity	NOUN
mkg-1066	36	160	and	and	CCONJ
mkg-1066	36	161	a	a	DET
mkg-1066	36	162	decrease	decrease	NOUN
mkg-1066	36	163	in	in	ADP
mkg-1066	36	164	the	the	DET
mkg-1066	36	165	incidence	incidence	NOUN
mkg-1066	36	166	of	of	ADP
mkg-1066	36	167	opportunistic	opportunistic	ADJ
mkg-1066	36	168	infections.11,21	infections.11,21	NOUN
mkg-1066	36	169	the	the	DET
mkg-1066	36	170	presence	presence	NOUN
mkg-1066	36	171	of	of	ADP
mkg-1066	36	172	oral	oral	ADJ
mkg-1066	36	173	candidiasis	candidiasis	NOUN
mkg-1066	36	174	in	in	ADP
mkg-1066	36	175	hiv	hiv	PROPN
mkg-1066	36	176	/	/	SYM
mkg-1066	36	177	aids	aids	PROPN
mkg-1066	36	178	patients	patient	NOUN
mkg-1066	36	179	after	after	ADP
mkg-1066	36	180	combination	combination	NOUN
mkg-1066	36	181	antiretroviral	antiretroviral	ADJ
mkg-1066	36	182	therapy	therapy	NOUN
mkg-1066	36	183	combination	combination	NOUN
mkg-1066	36	184	antiretroviral	antiretroviral	ADJ
mkg-1066	36	185	therapy	therapy	NOUN
mkg-1066	36	186	appears	appear	VERB
mkg-1066	36	187	have	have	VERB
mkg-1066	36	188	an	an	DET
mkg-1066	36	189	impact	impact	NOUN
mkg-1066	36	190	on	on	ADP
mkg-1066	36	191	the	the	DET
mkg-1066	36	192	oral	oral	ADJ
mkg-1066	36	193	opportunistic	opportunistic	ADJ
mkg-1066	36	194	infections	infection	NOUN
mkg-1066	36	195	.	.	PUNCT
mkg-1066	37	1	since	since	SCONJ
mkg-1066	37	2	the	the	DET
mkg-1066	37	3	introduction	introduction	NOUN
mkg-1066	37	4	of	of	ADP
mkg-1066	37	5	haart	haart	PROPN
mkg-1066	37	6	,	,	PUNCT
mkg-1066	37	7	there	there	PRON
mkg-1066	37	8	have	have	AUX
mkg-1066	37	9	been	be	AUX
mkg-1066	37	10	striking	strike	VERB
mkg-1066	37	11	changes	change	NOUN
mkg-1066	37	12	in	in	ADP
mkg-1066	37	13	the	the	DET
mkg-1066	37	14	frequency	frequency	NOUN
mkg-1066	37	15	and	and	CCONJ
mkg-1066	37	16	character	character	NOUN
mkg-1066	37	17	of	of	ADP
mkg-1066	37	18	the	the	DET
mkg-1066	37	19	oral	oral	ADJ
mkg-1066	37	20	complication	complication	NOUN
mkg-1066	37	21	of	of	ADP
mkg-1066	37	22	hiv	hiv	PROPN
mkg-1066	37	23	disease	disease	NOUN
mkg-1066	37	24	.	.	PUNCT
mkg-1066	38	1	antiretroviral	antiretroviral	ADJ
mkg-1066	38	2	drugs	drug	NOUN
mkg-1066	38	3	significantly	significantly	ADV
mkg-1066	38	4	lessen	lessen	VERB
mkg-1066	38	5	hiv	hiv	PROPN
mkg-1066	38	6	viral	viral	PROPN
mkg-1066	38	7	�	�	PROPN
mkg-1066	38	8	�	�	PROPN
mkg-1066	38	9	dent	dent	NOUN
mkg-1066	38	10	.	.	PUNCT
mkg-1066	39	1	j.	j.	PROPN
mkg-1066	39	2	(	(	PUNCT
mkg-1066	39	3	maj	maj	PROPN
mkg-1066	39	4	.	.	PROPN
mkg-1066	39	5	ked	ked	PROPN
mkg-1066	39	6	.	.	PUNCT
mkg-1066	40	1	gigi	gigi	PROPN
mkg-1066	40	2	)	)	PUNCT
mkg-1066	40	3	,	,	PUNCT
mkg-1066	40	4	vol	vol	NOUN
mkg-1066	40	5	.	.	PROPN
mkg-1066	41	1	40	40	NUM
mkg-1066	41	2	.	.	PUNCT
mkg-1066	42	1	no	no	INTJ
mkg-1066	42	2	.	.	NOUN
mkg-1066	42	3	1	1	NUM
mkg-1066	42	4	january	january	PROPN
mkg-1066	42	5	-	-	PUNCT
mkg-1066	42	6	march	march	PROPN
mkg-1066	42	7	2007	2007	NUM
mkg-1066	42	8	:	:	PUNCT
mkg-1066	42	9	16–19	16–19	NUM
mkg-1066	42	10	load	load	NOUN
mkg-1066	42	11	,	,	PUNCT
mkg-1066	42	12	increase	increase	VERB
mkg-1066	42	13	cd4	cd4	PROPN
mkg-1066	42	14	cell	cell	NOUN
mkg-1066	42	15	counts	count	NOUN
mkg-1066	42	16	and	and	CCONJ
mkg-1066	42	17	lessen	lessen	VERB
mkg-1066	42	18	the	the	DET
mkg-1066	42	19	frequency	frequency	NOUN
mkg-1066	42	20	and	and	CCONJ
mkg-1066	42	21	severity	severity	NOUN
mkg-1066	42	22	of	of	ADP
mkg-1066	42	23	oral	oral	ADJ
mkg-1066	42	24	opportunistic	opportunistic	ADJ
mkg-1066	42	25	infections	infection	NOUN
mkg-1066	42	26	.	.	PUNCT
mkg-1066	43	1	for	for	ADP
mkg-1066	43	2	instance	instance	NOUN
mkg-1066	43	3	,	,	PUNCT
mkg-1066	43	4	salobrena	salobrena	VERB
mkg-1066	43	5	et	et	PROPN
mkg-1066	43	6	al	al	PROPN
mkg-1066	43	7	.	.	PROPN
mkg-1066	43	8	,6	,6	PUNCT
mkg-1066	43	9	from	from	ADP
mkg-1066	43	10	spain	spain	PROPN
mkg-1066	43	11	had	have	AUX
mkg-1066	43	12	evaluated	evaluate	VERB
mkg-1066	43	13	the	the	DET
mkg-1066	43	14	oral	oral	ADJ
mkg-1066	43	15	lesions	lesion	NOUN
mkg-1066	43	16	from	from	ADP
mkg-1066	43	17	1995–2000	1995–2000	NUM
mkg-1066	43	18	and	and	CCONJ
mkg-1066	43	19	described	describe	VERB
mkg-1066	43	20	a	a	DET
mkg-1066	43	21	decrese	decrese	NOUN
mkg-1066	43	22	in	in	ADP
mkg-1066	43	23	the	the	DET
mkg-1066	43	24	prevalence	prevalence	NOUN
mkg-1066	43	25	of	of	ADP
mkg-1066	43	26	oral	oral	ADJ
mkg-1066	43	27	lesions	lesion	NOUN
mkg-1066	43	28	from	from	ADP
mkg-1066	43	29	22.4	22.4	NUM
mkg-1066	43	30	%	%	NOUN
mkg-1066	43	31	to	to	ADP
mkg-1066	43	32	5.2	5.2	NUM
mkg-1066	43	33	%	%	NOUN
mkg-1066	43	34	.	.	PUNCT
mkg-1066	44	1	similarly	similarly	ADV
mkg-1066	44	2	,	,	PUNCT
mkg-1066	44	3	patton	patton	PROPN
mkg-1066	44	4	et	et	PROPN
mkg-1066	44	5	al.9	al.9	PROPN
mkg-1066	44	6	reported	report	VERB
mkg-1066	44	7	significant	significant	ADJ
mkg-1066	44	8	decreases	decrease	NOUN
mkg-1066	44	9	in	in	ADP
mkg-1066	44	10	the	the	DET
mkg-1066	44	11	prevalence	prevalence	NOUN
mkg-1066	44	12	of	of	ADP
mkg-1066	44	13	hiv	hiv	PROPN
mkg-1066	44	14	related	relate	VERB
mkg-1066	44	15	oral	oral	ADJ
mkg-1066	44	16	diseases	disease	NOUN
mkg-1066	44	17	with	with	ADP
mkg-1066	44	18	haart	haart	PROPN
mkg-1066	44	19	(	(	PUNCT
mkg-1066	44	20	from	from	ADP
mkg-1066	44	21	47.6	47.6	NUM
mkg-1066	44	22	%	%	NOUN
mkg-1066	44	23	to	to	ADP
mkg-1066	44	24	37.5	37.5	NUM
mkg-1066	44	25	%	%	NOUN
mkg-1066	44	26	)	)	PUNCT
mkg-1066	44	27	in	in	ADP
mkg-1066	44	28	us	us	PROPN
mkg-1066	44	29	patients	patient	NOUN
mkg-1066	44	30	.	.	PUNCT
mkg-1066	45	1	some	some	DET
mkg-1066	45	2	studies	study	NOUN
mkg-1066	45	3	specifically	specifically	ADV
mkg-1066	45	4	demonstrated	demonstrate	VERB
mkg-1066	45	5	the	the	DET
mkg-1066	45	6	decrease	decrease	NOUN
mkg-1066	45	7	prevalence	prevalence	NOUN
mkg-1066	45	8	of	of	ADP
mkg-1066	45	9	oral	oral	ADJ
mkg-1066	45	10	candidiasis	candidiasis	NOUN
mkg-1066	45	11	with	with	ADP
mkg-1066	45	12	the	the	DET
mkg-1066	45	13	widespread	widespread	ADJ
mkg-1066	45	14	used	use	VERB
mkg-1066	45	15	of	of	ADP
mkg-1066	45	16	haart	haart	PROPN
mkg-1066	45	17	.	.	PUNCT
mkg-1066	46	1	a	a	DET
mkg-1066	46	2	study	study	NOUN
mkg-1066	46	3	in	in	ADP
mkg-1066	46	4	united	united	PROPN
mkg-1066	46	5	kingdom	kingdom	PROPN
mkg-1066	46	6	by	by	ADP
mkg-1066	46	7	tappuni	tappuni	PROPN
mkg-1066	46	8	and	and	CCONJ
mkg-1066	46	9	fleming	fleming	NOUN
mkg-1066	46	10	comparing	compare	VERB
mkg-1066	46	11	subjects	subject	NOUN
mkg-1066	46	12	on	on	ADP
mkg-1066	46	13	haart	haart	PROPN
mkg-1066	46	14	group	group	PROPN
mkg-1066	46	15	and	and	CCONJ
mkg-1066	46	16	non	non	ADJ
mkg-1066	46	17	haart	haart	PROPN
mkg-1066	46	18	group	group	PROPN
mkg-1066	46	19	.	.	PUNCT
mkg-1066	47	1	from	from	ADP
mkg-1066	47	2	this	this	DET
mkg-1066	47	3	study	study	NOUN
mkg-1066	47	4	showed	show	VERB
mkg-1066	47	5	that	that	SCONJ
mkg-1066	47	6	subjects	subject	NOUN
mkg-1066	47	7	on	on	ADP
mkg-1066	47	8	haart	haart	PROPN
mkg-1066	47	9	group	group	PROPN
mkg-1066	47	10	had	have	VERB
mkg-1066	47	11	significantly	significantly	ADV
mkg-1066	47	12	less	less	ADV
mkg-1066	47	13	oral	oral	ADJ
mkg-1066	47	14	candidiasis	candidiasis	NOUN
mkg-1066	47	15	than	than	SCONJ
mkg-1066	47	16	did	do	VERB
mkg-1066	47	17	subjects	subject	NOUN
mkg-1066	47	18	on	on	ADP
mkg-1066	47	19	non	non	PROPN
mkg-1066	47	20	haart	haart	PROPN
mkg-1066	47	21	group	group	PROPN
mkg-1066	47	22	,	,	PUNCT
mkg-1066	47	23	that	that	PRON
mkg-1066	47	24	is	be	AUX
mkg-1066	47	25	pseudomembranous	pseudomembranous	ADJ
mkg-1066	47	26	candidiasis	candidiasis	NOUN
mkg-1066	47	27	variant	variant	NOUN
mkg-1066	47	28	from	from	ADP
mkg-1066	47	29	12	12	NUM
mkg-1066	47	30	%	%	NOUN
mkg-1066	47	31	to	to	PART
mkg-1066	47	32	8	8	NUM
mkg-1066	47	33	%	%	NOUN
mkg-1066	47	34	and	and	CCONJ
mkg-1066	47	35	erythematous	erythematous	ADJ
mkg-1066	47	36	variant	variant	NOUN
mkg-1066	47	37	from	from	ADP
mkg-1066	47	38	25	25	NUM
mkg-1066	47	39	%	%	NOUN
mkg-1066	47	40	to	to	ADP
mkg-1066	47	41	8%.3	8%.3	NUM
mkg-1066	47	42	a	a	DET
mkg-1066	47	43	study	study	NOUN
mkg-1066	47	44	on	on	ADP
mkg-1066	47	45	807	807	NUM
mkg-1066	47	46	hiv	hiv	PROPN
mkg-1066	47	47	/	/	SYM
mkg-1066	47	48	aids	aids	PROPN
mkg-1066	47	49	patients	patient	NOUN
mkg-1066	47	50	in	in	ADP
mkg-1066	47	51	spain	spain	PROPN
mkg-1066	47	52	,	,	PUNCT
mkg-1066	47	53	found	find	VERB
mkg-1066	47	54	a	a	DET
mkg-1066	47	55	declining	decline	VERB
mkg-1066	47	56	rate	rate	NOUN
mkg-1066	47	57	of	of	ADP
mkg-1066	47	58	oral	oral	ADJ
mkg-1066	47	59	candidiasis	candidiasis	NOUN
mkg-1066	47	60	following	follow	VERB
mkg-1066	47	61	the	the	DET
mkg-1066	47	62	introduction	introduction	NOUN
mkg-1066	47	63	of	of	ADP
mkg-1066	47	64	haart	haart	PROPN
mkg-1066	47	65	with	with	ADP
mkg-1066	47	66	stabilization	stabilization	NOUN
mkg-1066	47	67	or	or	CCONJ
mkg-1066	47	68	improvement	improvement	NOUN
mkg-1066	47	69	in	in	ADP
mkg-1066	47	70	the	the	DET
mkg-1066	47	71	immune	immune	ADJ
mkg-1066	47	72	status	status	NOUN
mkg-1066	47	73	of	of	ADP
mkg-1066	47	74	patients.6	patients.6	PROPN
mkg-1066	47	75	cattopadhyay	cattopadhyay	NOUN
mkg-1066	47	76	et	et	NOUN
mkg-1066	47	77	al.22	al.22	PROPN
mkg-1066	47	78	also	also	ADV
mkg-1066	47	79	reported	report	VERB
mkg-1066	47	80	decreases	decrease	NOUN
mkg-1066	47	81	in	in	ADP
mkg-1066	47	82	oral	oral	ADJ
mkg-1066	47	83	candidiasis	candidiasis	NOUN
mkg-1066	47	84	in	in	ADP
mkg-1066	47	85	283	283	NUM
mkg-1066	47	86	patients	patient	NOUN
mkg-1066	47	87	in	in	ADP
mkg-1066	47	88	north	north	PROPN
mkg-1066	47	89	carolina	carolina	PROPN
mkg-1066	47	90	.	.	PUNCT
mkg-1066	48	1	the	the	DET
mkg-1066	48	2	european	european	PROPN
mkg-1066	48	3	community	community	NOUN
mkg-1066	48	4	clearinghouse	clearinghouse	NOUN
mkg-1066	48	5	on	on	ADP
mkg-1066	48	6	oral	oral	ADJ
mkg-1066	48	7	problems	problem	NOUN
mkg-1066	48	8	related	relate	VERB
mkg-1066	48	9	to	to	ADP
mkg-1066	48	10	hiv	hiv	PROPN
mkg-1066	48	11	infection	infection	NOUN
mkg-1066	48	12	and	and	CCONJ
mkg-1066	48	13	who	who	PRON
mkg-1066	48	14	collaborating	collaborate	VERB
mkg-1066	48	15	centre	centre	NOUN
mkg-1066	48	16	showed	show	VERB
mkg-1066	48	17	the	the	DET
mkg-1066	48	18	greatest	great	ADJ
mkg-1066	48	19	reduction	reduction	NOUN
mkg-1066	48	20	in	in	ADP
mkg-1066	48	21	the	the	DET
mkg-1066	48	22	prevalence	prevalence	NOUN
mkg-1066	48	23	of	of	ADP
mkg-1066	48	24	oral	oral	ADJ
mkg-1066	48	25	candidiasis	candidiasis	NOUN
mkg-1066	48	26	(	(	PUNCT
mkg-1066	48	27	from	from	ADP
mkg-1066	48	28	51.4	51.4	NUM
mkg-1066	48	29	%	%	NOUN
mkg-1066	48	30	to	to	ADP
mkg-1066	48	31	17.1	17.1	NUM
mkg-1066	48	32	%	%	NOUN
mkg-1066	48	33	)	)	PUNCT
mkg-1066	48	34	,	,	PUNCT
mkg-1066	48	35	especially	especially	ADV
mkg-1066	48	36	of	of	ADP
mkg-1066	48	37	the	the	DET
mkg-1066	48	38	pseudomembranous	pseudomembranous	ADJ
mkg-1066	48	39	variant.23	variant.23	NOUN
mkg-1066	48	40	discussion	discussion	NOUN
mkg-1066	48	41	at	at	ADP
mkg-1066	48	42	present	present	ADJ
mkg-1066	48	43	,	,	PUNCT
mkg-1066	48	44	the	the	DET
mkg-1066	48	45	recommended	recommend	VERB
mkg-1066	48	46	treatment	treatment	NOUN
mkg-1066	48	47	for	for	ADP
mkg-1066	48	48	hiv	hiv	PROPN
mkg-1066	48	49	infection	infection	NOUN
mkg-1066	48	50	is	be	AUX
mkg-1066	48	51	haart	haart	PROPN
mkg-1066	48	52	,	,	PUNCT
mkg-1066	48	53	which	which	PRON
mkg-1066	48	54	consists	consist	VERB
mkg-1066	48	55	of	of	ADP
mkg-1066	48	56	a	a	DET
mkg-1066	48	57	combination	combination	NOUN
mkg-1066	48	58	of	of	ADP
mkg-1066	48	59	at	at	ADV
mkg-1066	48	60	least	least	ADV
mkg-1066	48	61	3	3	NUM
mkg-1066	48	62	antiviral	antiviral	ADJ
mkg-1066	48	63	drugs	drug	NOUN
mkg-1066	48	64	,	,	PUNCT
mkg-1066	48	65	2	2	NUM
mkg-1066	48	66	nrti	nrti	NOUN
mkg-1066	48	67	with	with	ADP
mkg-1066	48	68	either	either	CCONJ
mkg-1066	48	69	a	a	DET
mkg-1066	48	70	pi	pi	NOUN
mkg-1066	48	71	or	or	CCONJ
mkg-1066	48	72	an	an	DET
mkg-1066	48	73	nnrti	nnrti	NOUN
mkg-1066	48	74	.	.	PUNCT
mkg-1066	49	1	this	this	DET
mkg-1066	49	2	combination	combination	NOUN
mkg-1066	49	3	attacking	attack	VERB
mkg-1066	49	4	the	the	DET
mkg-1066	49	5	virus	virus	NOUN
mkg-1066	49	6	at	at	ADP
mkg-1066	49	7	different	different	ADJ
mkg-1066	49	8	stages	stage	NOUN
mkg-1066	49	9	of	of	ADP
mkg-1066	49	10	its	its	PRON
mkg-1066	49	11	replication	replication	NOUN
mkg-1066	49	12	cycle	cycle	NOUN
mkg-1066	49	13	.	.	PUNCT
mkg-1066	50	1	combination	combination	NOUN
mkg-1066	50	2	therapies	therapy	NOUN
mkg-1066	50	3	appears	appear	VERB
mkg-1066	50	4	to	to	PART
mkg-1066	50	5	have	have	VERB
mkg-1066	50	6	a	a	DET
mkg-1066	50	7	critical	critical	ADJ
mkg-1066	50	8	role	role	NOUN
mkg-1066	50	9	in	in	ADP
mkg-1066	50	10	the	the	DET
mkg-1066	50	11	prevention	prevention	NOUN
mkg-1066	50	12	of	of	ADP
mkg-1066	50	13	oral	oral	ADJ
mkg-1066	50	14	manifestations	manifestation	NOUN
mkg-1066	50	15	of	of	ADP
mkg-1066	50	16	hiv	hiv	PROPN
mkg-1066	50	17	,	,	PUNCT
mkg-1066	50	18	probably	probably	ADV
mkg-1066	50	19	because	because	SCONJ
mkg-1066	50	20	of	of	ADP
mkg-1066	50	21	its	its	PRON
mkg-1066	50	22	role	role	NOUN
mkg-1066	50	23	in	in	ADP
mkg-1066	50	24	the	the	DET
mkg-1066	50	25	reconstitution	reconstitution	NOUN
mkg-1066	50	26	of	of	ADP
mkg-1066	50	27	the	the	DET
mkg-1066	50	28	immune	immune	ADJ
mkg-1066	50	29	system.3	system.3	NOUN
mkg-1066	50	30	as	as	SCONJ
mkg-1066	50	31	we	we	PRON
mkg-1066	50	32	know	know	VERB
mkg-1066	50	33	,	,	PUNCT
mkg-1066	50	34	oral	oral	ADJ
mkg-1066	50	35	lesions	lesion	NOUN
mkg-1066	50	36	strongly	strongly	ADV
mkg-1066	50	37	associated	associate	VERB
mkg-1066	50	38	with	with	ADP
mkg-1066	50	39	hiv	hiv	PROPN
mkg-1066	50	40	,	,	PUNCT
mkg-1066	50	41	such	such	ADJ
mkg-1066	50	42	as	as	ADP
mkg-1066	50	43	oral	oral	ADJ
mkg-1066	50	44	candidiasis	candidiasis	NOUN
mkg-1066	50	45	,	,	PUNCT
mkg-1066	50	46	hairy	hairy	ADJ
mkg-1066	50	47	leukoplakia	leukoplakia	NOUN
mkg-1066	50	48	,	,	PUNCT
mkg-1066	50	49	kaposi	kaposi	PROPN
mkg-1066	50	50	’s	’s	PART
mkg-1066	50	51	sarcoma	sarcoma	NOUN
mkg-1066	50	52	and	and	CCONJ
mkg-1066	50	53	necrotizing	necrotize	VERB
mkg-1066	50	54	periodontal	periodontal	ADJ
mkg-1066	50	55	diseases	disease	NOUN
mkg-1066	50	56	,	,	PUNCT
mkg-1066	50	57	are	be	AUX
mkg-1066	50	58	also	also	ADV
mkg-1066	50	59	strongly	strongly	ADV
mkg-1066	50	60	associated	associate	VERB
mkg-1066	50	61	with	with	ADP
mkg-1066	50	62	reduced	reduce	VERB
mkg-1066	50	63	of	of	ADP
mkg-1066	50	64	immune	immune	ADJ
mkg-1066	50	65	system.9	system.9	PROPN
mkg-1066	50	66	in	in	ADP
mkg-1066	50	67	the	the	DET
mkg-1066	50	68	reduction	reduction	NOUN
mkg-1066	50	69	of	of	ADP
mkg-1066	50	70	frequency	frequency	NOUN
mkg-1066	50	71	of	of	ADP
mkg-1066	50	72	oral	oral	ADJ
mkg-1066	50	73	candidiasis	candidiasis	NOUN
mkg-1066	50	74	,	,	PUNCT
mkg-1066	50	75	combination	combination	NOUN
mkg-1066	50	76	therapies	therapy	NOUN
mkg-1066	50	77	have	have	VERB
mkg-1066	50	78	several	several	ADJ
mkg-1066	50	79	mechanisms	mechanism	NOUN
mkg-1066	50	80	.	.	PUNCT
mkg-1066	51	1	one	one	NUM
mkg-1066	51	2	of	of	ADP
mkg-1066	51	3	them	they	PRON
mkg-1066	51	4	,	,	PUNCT
mkg-1066	51	5	with	with	ADP
mkg-1066	51	6	these	these	DET
mkg-1066	51	7	regimens	regimen	NOUN
mkg-1066	51	8	demonstrated	demonstrate	VERB
mkg-1066	51	9	increases	increase	NOUN
mkg-1066	51	10	cd4	cd4	PROPN
mkg-1066	51	11	cells	cell	NOUN
mkg-1066	51	12	counts	count	NOUN
mkg-1066	51	13	,	,	PUNCT
mkg-1066	51	14	decreases	decrease	VERB
mkg-1066	51	15	viral	viral	ADJ
mkg-1066	51	16	load	load	NOUN
mkg-1066	51	17	as	as	ADV
mkg-1066	51	18	much	much	ADV
mkg-1066	51	19	as	as	ADP
mkg-1066	51	20	possible	possible	ADJ
mkg-1066	51	21	(	(	PUNCT
mkg-1066	51	22	below	below	ADP
mkg-1066	51	23	3,000	3,000	NUM
mkg-1066	51	24	copies	copy	NOUN
mkg-1066	51	25	/	/	SYM
mkg-1066	51	26	ml	ml	NOUN
mkg-1066	51	27	)	)	PUNCT
mkg-1066	51	28	.	.	PUNCT
mkg-1066	52	1	such	such	DET
mkg-1066	52	2	a	a	DET
mkg-1066	52	3	thing	thing	NOUN
mkg-1066	52	4	related	relate	VERB
mkg-1066	52	5	an	an	DET
mkg-1066	52	6	improving	improve	VERB
mkg-1066	52	7	immunity	immunity	NOUN
mkg-1066	52	8	thereby	thereby	ADV
mkg-1066	52	9	reduces	reduce	VERB
mkg-1066	52	10	the	the	DET
mkg-1066	52	11	potential	potential	ADJ
mkg-1066	52	12	risk	risk	NOUN
mkg-1066	52	13	of	of	ADP
mkg-1066	52	14	opportunistic	opportunistic	ADJ
mkg-1066	52	15	infections	infection	NOUN
mkg-1066	52	16	such	such	ADJ
mkg-1066	52	17	as	as	ADP
mkg-1066	52	18	candida	candida	PROPN
mkg-1066	52	19	species.3,6,9,14	species.3,6,9,14	ADV
mkg-1066	52	20	in	in	ADP
mkg-1066	52	21	addition	addition	NOUN
mkg-1066	52	22	,	,	PUNCT
mkg-1066	52	23	combination	combination	NOUN
mkg-1066	52	24	therapies	therapy	NOUN
mkg-1066	52	25	has	have	AUX
mkg-1066	52	26	been	be	AUX
mkg-1066	52	27	significantly	significantly	ADV
mkg-1066	52	28	associated	associate	VERB
mkg-1066	52	29	with	with	ADP
mkg-1066	52	30	increases	increase	NOUN
mkg-1066	52	31	in	in	ADP
mkg-1066	52	32	neutrophils	neutrophil	NOUN
mkg-1066	52	33	count	count	NOUN
mkg-1066	52	34	.	.	PUNCT
mkg-1066	53	1	neutrophils	neutrophil	NOUN
mkg-1066	53	2	plays	play	VERB
mkg-1066	53	3	a	a	DET
mkg-1066	53	4	pivotal	pivotal	ADJ
mkg-1066	53	5	role	role	NOUN
mkg-1066	53	6	in	in	ADP
mkg-1066	53	7	the	the	DET
mkg-1066	53	8	defense	defense	NOUN
mkg-1066	53	9	mechanisms	mechanism	NOUN
mkg-1066	53	10	against	against	ADP
mkg-1066	53	11	candida	candida	PROPN
mkg-1066	53	12	.	.	PUNCT
mkg-1066	54	1	neutrophils	neutrophil	NOUN
mkg-1066	54	2	produce	produce	VERB
mkg-1066	54	3	granulocyte	granulocyte	ADJ
mkg-1066	54	4	-	-	PUNCT
mkg-1066	54	5	colony	colony	NOUN
mkg-1066	54	6	stimulating	stimulate	VERB
mkg-1066	54	7	factors	factor	NOUN
mkg-1066	54	8	(	(	PUNCT
mkg-1066	54	9	g	g	NOUN
mkg-1066	54	10	-	-	PUNCT
mkg-1066	54	11	csf	csf	NOUN
mkg-1066	54	12	)	)	PUNCT
mkg-1066	54	13	and	and	CCONJ
mkg-1066	54	14	granulocyte	granulocyte	ADJ
mkg-1066	54	15	macrophagecolony	macrophagecolony	ADP
mkg-1066	54	16	stimulating	stimulate	VERB
mkg-1066	54	17	factors	factor	NOUN
mkg-1066	54	18	(	(	PUNCT
mkg-1066	54	19	gm	gm	NOUN
mkg-1066	54	20	-	-	PUNCT
mkg-1066	54	21	csf	csf	NOUN
mkg-1066	54	22	)	)	PUNCT
mkg-1066	54	23	that	that	PRON
mkg-1066	54	24	induce	induce	VERB
mkg-1066	54	25	improvement	improvement	NOUN
mkg-1066	54	26	of	of	ADP
mkg-1066	54	27	their	their	PRON
mkg-1066	54	28	functionality	functionality	NOUN
mkg-1066	54	29	thereby	thereby	ADV
mkg-1066	54	30	might	might	AUX
mkg-1066	54	31	inhibit	inhibit	VERB
mkg-1066	54	32	oral	oral	ADJ
mkg-1066	54	33	candidiasis.9,16,23	candidiasis.9,16,23	PROPN
mkg-1066	54	34	on	on	ADP
mkg-1066	54	35	the	the	DET
mkg-1066	54	36	other	other	ADJ
mkg-1066	54	37	hand	hand	NOUN
mkg-1066	54	38	,	,	PUNCT
mkg-1066	54	39	decreased	decrease	VERB
mkg-1066	54	40	in	in	ADP
mkg-1066	54	41	prevalence	prevalence	NOUN
mkg-1066	54	42	of	of	ADP
mkg-1066	54	43	oral	oral	ADJ
mkg-1066	54	44	candidiasis	candidiasis	NOUN
mkg-1066	54	45	in	in	ADP
mkg-1066	54	46	hiv	hiv	PROPN
mkg-1066	54	47	-	-	PUNCT
mkg-1066	54	48	infected	infect	VERB
mkg-1066	54	49	patients	patient	NOUN
mkg-1066	54	50	might	might	AUX
mkg-1066	54	51	also	also	ADV
mkg-1066	54	52	attributed	attribute	VERB
mkg-1066	54	53	to	to	ADP
mkg-1066	54	54	the	the	DET
mkg-1066	54	55	direct	direct	ADJ
mkg-1066	54	56	effect	effect	NOUN
mkg-1066	54	57	of	of	ADP
mkg-1066	54	58	antiretroviral	antiretroviral	ADJ
mkg-1066	54	59	protease	protease	NOUN
mkg-1066	54	60	inhibitor	inhibitor	NOUN
mkg-1066	54	61	over	over	ADP
mkg-1066	54	62	secretory	secretory	ADJ
mkg-1066	54	63	aspartyl	aspartyl	NOUN
mkg-1066	54	64	protease	protease	NOUN
mkg-1066	54	65	,	,	PUNCT
mkg-1066	54	66	a	a	DET
mkg-1066	54	67	potent	potent	ADJ
mkg-1066	54	68	virulence	virulence	NOUN
mkg-1066	54	69	factor	factor	NOUN
mkg-1066	54	70	of	of	ADP
mkg-1066	54	71	candida	candida	PROPN
mkg-1066	54	72	species.11	species.11	ADJ
mkg-1066	54	73	protease	protease	NOUN
mkg-1066	54	74	inhibitor	inhibitor	NOUN
mkg-1066	54	75	therapy	therapy	NOUN
mkg-1066	54	76	has	have	VERB
mkg-1066	54	77	capacity	capacity	NOUN
mkg-1066	54	78	inhibited	inhibit	VERB
mkg-1066	54	79	production	production	NOUN
mkg-1066	54	80	and	and	CCONJ
mkg-1066	54	81	activity	activity	NOUN
mkg-1066	54	82	of	of	ADP
mkg-1066	54	83	secretory	secretory	ADJ
mkg-1066	54	84	aspartyl	aspartyl	NOUN
mkg-1066	54	85	protease	protease	NOUN
mkg-1066	54	86	,	,	PUNCT
mkg-1066	54	87	which	which	PRON
mkg-1066	54	88	are	be	AUX
mkg-1066	54	89	involved	involve	VERB
mkg-1066	54	90	in	in	ADP
mkg-1066	54	91	candida	candida	PROPN
mkg-1066	54	92	adherence.14,22	adherence.14,22	NOUN
mkg-1066	54	93	some	some	PRON
mkg-1066	54	94	believe	believe	VERB
mkg-1066	54	95	that	that	SCONJ
mkg-1066	54	96	the	the	DET
mkg-1066	54	97	antifungal	antifungal	ADJ
mkg-1066	54	98	effect	effect	NOUN
mkg-1066	54	99	of	of	ADP
mkg-1066	54	100	antiretroviral	antiretroviral	ADJ
mkg-1066	54	101	protease	protease	NOUN
mkg-1066	54	102	inhibitor	inhibitor	NOUN
mkg-1066	54	103	is	be	AUX
mkg-1066	54	104	equivalent	equivalent	ADJ
mkg-1066	54	105	to	to	ADP
mkg-1066	54	106	fluconazole.11	fluconazole.11	PROPN
mkg-1066	54	107	however	however	ADV
mkg-1066	54	108	,	,	PUNCT
mkg-1066	54	109	there	there	PRON
mkg-1066	54	110	were	be	VERB
mkg-1066	54	111	systemic	systemic	ADJ
mkg-1066	54	112	and	and	CCONJ
mkg-1066	54	113	oral	oral	ADJ
mkg-1066	54	114	adverse	adverse	ADJ
mkg-1066	54	115	effects	effect	NOUN
mkg-1066	54	116	can	can	AUX
mkg-1066	54	117	arise	arise	VERB
mkg-1066	54	118	with	with	ADP
mkg-1066	54	119	the	the	DET
mkg-1066	54	120	used	use	VERB
mkg-1066	54	121	of	of	ADP
mkg-1066	54	122	combination	combination	NOUN
mkg-1066	54	123	therapies	therapy	NOUN
mkg-1066	54	124	.	.	PUNCT
mkg-1066	55	1	systemic	systemic	ADJ
mkg-1066	55	2	effects	effect	NOUN
mkg-1066	55	3	include	include	VERB
mkg-1066	55	4	dry	dry	ADJ
mkg-1066	55	5	skin	skin	NOUN
mkg-1066	55	6	,	,	PUNCT
mkg-1066	55	7	headache	headache	NOUN
mkg-1066	55	8	,	,	PUNCT
mkg-1066	55	9	nausea	nausea	NOUN
mkg-1066	55	10	,	,	PUNCT
mkg-1066	55	11	neuropathy	neuropathy	ADJ
mkg-1066	55	12	and	and	CCONJ
mkg-1066	55	13	liver	liver	NOUN
mkg-1066	55	14	disorder	disorder	NOUN
mkg-1066	55	15	.	.	PUNCT
mkg-1066	56	1	on	on	ADP
mkg-1066	56	2	the	the	DET
mkg-1066	56	3	orofacial	orofacial	ADJ
mkg-1066	56	4	regions	region	NOUN
mkg-1066	56	5	,	,	PUNCT
mkg-1066	56	6	haart	haart	PROPN
mkg-1066	56	7	seems	seem	VERB
mkg-1066	56	8	to	to	PART
mkg-1066	56	9	increase	increase	VERB
mkg-1066	56	10	the	the	DET
mkg-1066	56	11	incidence	incidence	NOUN
mkg-1066	56	12	of	of	ADP
mkg-1066	56	13	hiv	hiv	PROPN
mkg-1066	56	14	-	-	PUNCT
mkg-1066	56	15	related	relate	VERB
mkg-1066	56	16	salivary	salivary	ADJ
mkg-1066	56	17	gland	gland	NOUN
mkg-1066	56	18	disease	disease	NOUN
mkg-1066	56	19	,	,	PUNCT
mkg-1066	56	20	especially	especially	ADV
mkg-1066	56	21	enlargement	enlargement	NOUN
mkg-1066	56	22	of	of	ADP
mkg-1066	56	23	parotid	parotid	ADJ
mkg-1066	56	24	gland	gland	NOUN
mkg-1066	56	25	.	.	PUNCT
mkg-1066	57	1	the	the	DET
mkg-1066	57	2	other	other	ADJ
mkg-1066	57	3	oral	oral	ADJ
mkg-1066	57	4	side	side	NOUN
mkg-1066	57	5	effects	effect	NOUN
mkg-1066	57	6	are	be	AUX
mkg-1066	57	7	mouth	mouth	NOUN
mkg-1066	57	8	ulcer	ulcer	NOUN
mkg-1066	57	9	and	and	CCONJ
mkg-1066	57	10	oral	oral	ADJ
mkg-1066	57	11	warts.24	warts.24	NOUN
mkg-1066	57	12	in	in	ADP
mkg-1066	57	13	conclusion	conclusion	NOUN
mkg-1066	57	14	,	,	PUNCT
mkg-1066	57	15	oral	oral	ADJ
mkg-1066	57	16	candidal	candidal	ADJ
mkg-1066	57	17	infection	infection	NOUN
mkg-1066	57	18	in	in	ADP
mkg-1066	57	19	hiv	hiv	PROPN
mkg-1066	57	20	-	-	PUNCT
mkg-1066	57	21	infected	infect	VERB
mkg-1066	57	22	patients	patient	NOUN
mkg-1066	57	23	have	have	AUX
mkg-1066	57	24	shown	show	VERB
mkg-1066	57	25	a	a	DET
mkg-1066	57	26	decrease	decrease	NOUN
mkg-1066	57	27	in	in	ADP
mkg-1066	57	28	the	the	DET
mkg-1066	57	29	era	era	NOUN
mkg-1066	57	30	of	of	ADP
mkg-1066	57	31	haart	haart	PROPN
mkg-1066	57	32	.	.	PUNCT
mkg-1066	58	1	haart	haart	PROPN
mkg-1066	58	2	decreases	decrease	VERB
mkg-1066	58	3	hiv	hiv	PROPN
mkg-1066	58	4	viral	viral	ADJ
mkg-1066	58	5	load	load	NOUN
mkg-1066	58	6	and	and	CCONJ
mkg-1066	58	7	lead	lead	VERB
mkg-1066	58	8	to	to	ADP
mkg-1066	58	9	increases	increase	NOUN
mkg-1066	58	10	of	of	ADP
mkg-1066	58	11	cd4	cd4	PROPN
mkg-1066	58	12	lymphocytes	lymphocyte	NOUN
mkg-1066	58	13	count	count	NOUN
mkg-1066	58	14	,	,	PUNCT
mkg-1066	58	15	causing	cause	VERB
mkg-1066	58	16	an	an	DET
mkg-1066	58	17	improvement	improvement	NOUN
mkg-1066	58	18	of	of	ADP
mkg-1066	58	19	immunity	immunity	NOUN
mkg-1066	58	20	.	.	PUNCT
mkg-1066	59	1	references	reference	NOUN
mkg-1066	59	2	1	1	NUM
mkg-1066	59	3	.	.	PUNCT
mkg-1066	60	1	muma	muma	PROPN
mkg-1066	60	2	rd	rd	PROPN
mkg-1066	60	3	,	,	PUNCT
mkg-1066	60	4	lyons	lyons	PROPN
mkg-1066	60	5	ab	ab	PROPN
mkg-1066	60	6	,	,	PUNCT
mkg-1066	60	7	borweki	borweki	PROPN
mkg-1066	60	8	mj	mj	PROPN
mkg-1066	60	9	.	.	PROPN
mkg-1066	60	10	hiv	hiv	PROPN
mkg-1066	60	11	manual	manual	PROPN
mkg-1066	60	12	untuk	untuk	PROPN
mkg-1066	60	13	tenaga	tenaga	PROPN
mkg-1066	60	14	kesehatan	kesehatan	PROPN
mkg-1066	60	15	.	.	PUNCT
mkg-1066	61	1	shinta	shinta	PROPN
mkg-1066	61	2	prawitasari	prawitasari	PROPN
mkg-1066	61	3	.	.	PUNCT
mkg-1066	62	1	jakarta	jakarta	PROPN
mkg-1066	62	2	:	:	PUNCT
mkg-1066	62	3	egc	egc	PROPN
mkg-1066	62	4	;	;	PUNCT
mkg-1066	62	5	1997	1997	NUM
mkg-1066	62	6	.	.	PUNCT
mkg-1066	63	1	p.	p.	NOUN
mkg-1066	63	2	9–21	9–21	PROPN
mkg-1066	63	3	.	.	PUNCT
mkg-1066	64	1	2	2	NUM
mkg-1066	64	2	.	.	X
mkg-1066	64	3	yeh	yeh	PROPN
mkg-1066	64	4	ck	ck	PROPN
mkg-1066	64	5	,	,	PUNCT
mkg-1066	64	6	puttaiah	puttaiah	NOUN
mkg-1066	64	7	r	r	NOUN
mkg-1066	64	8	,	,	PUNCT
mkg-1066	64	9	cottone	cottone	PROPN
mkg-1066	64	10	ja	ja	PROPN
mkg-1066	64	11	.	.	PUNCT
mkg-1066	65	1	human	human	ADJ
mkg-1066	65	2	immunodeficiency	immunodeficiency	NOUN
mkg-1066	65	3	virus	virus	NOUN
mkg-1066	65	4	infection	infection	NOUN
mkg-1066	65	5	,	,	PUNCT
mkg-1066	65	6	acquired	acquire	VERB
mkg-1066	65	7	immune	immune	ADJ
mkg-1066	65	8	deficiency	deficiency	NOUN
mkg-1066	65	9	syndrome	syndrome	NOUN
mkg-1066	65	10	,	,	PUNCT
mkg-1066	65	11	and	and	CCONJ
mkg-1066	65	12	related	related	ADJ
mkg-1066	65	13	infection	infection	NOUN
mkg-1066	65	14	.	.	PUNCT
mkg-1066	66	1	in	in	ADP
mkg-1066	66	2	:	:	PUNCT
mkg-1066	66	3	cottone	cottone	PROPN
mkg-1066	66	4	ja	ja	PROPN
mkg-1066	66	5	,	,	PUNCT
mkg-1066	66	6	terezhalmy	terezhalmy	PROPN
mkg-1066	66	7	gt	gt	PROPN
mkg-1066	66	8	,	,	PUNCT
mkg-1066	66	9	molinary	molinary	PROPN
mkg-1066	66	10	ja	ja	PROPN
mkg-1066	66	11	,	,	PUNCT
mkg-1066	66	12	editors	editor	NOUN
mkg-1066	66	13	.	.	PUNCT
mkg-1066	66	14	practical	practical	ADJ
mkg-1066	66	15	infection	infection	NOUN
mkg-1066	66	16	control	control	NOUN
mkg-1066	66	17	in	in	ADP
mkg-1066	66	18	dentistry	dentistry	NOUN
mkg-1066	66	19	.	.	PUNCT
mkg-1066	67	1	2nd	2nd	ADJ
mkg-1066	67	2	ed	ed	NOUN
mkg-1066	67	3	.	.	PUNCT
mkg-1066	68	1	baltimore	baltimore	PROPN
mkg-1066	68	2	:	:	PUNCT
mkg-1066	68	3	williams	williams	PROPN
mkg-1066	68	4	&	&	CCONJ
mkg-1066	68	5	wilkins	wilkins	PROPN
mkg-1066	68	6	;	;	PUNCT
mkg-1066	68	7	1996	1996	NUM
mkg-1066	68	8	.	.	PUNCT
mkg-1066	69	1	p.	p.	NOUN
mkg-1066	69	2	48–55	48–55	NUM
mkg-1066	69	3	.	.	PUNCT
mkg-1066	70	1	3	3	X
mkg-1066	70	2	.	.	X
mkg-1066	70	3	tappuni	tappuni	PROPN
mkg-1066	70	4	ar	ar	PROPN
mkg-1066	70	5	,	,	PUNCT
mkg-1066	70	6	fleming	fleme	VERB
mkg-1066	70	7	gjp	gjp	NOUN
mkg-1066	70	8	.	.	PUNCT
mkg-1066	71	1	the	the	DET
mkg-1066	71	2	effect	effect	NOUN
mkg-1066	71	3	of	of	ADP
mkg-1066	71	4	antiretroviral	antiretroviral	ADJ
mkg-1066	71	5	therapy	therapy	NOUN
mkg-1066	71	6	on	on	ADP
mkg-1066	71	7	the	the	DET
mkg-1066	71	8	prevalence	prevalence	NOUN
mkg-1066	71	9	of	of	ADP
mkg-1066	71	10	oral	oral	ADJ
mkg-1066	71	11	manifestations	manifestation	NOUN
mkg-1066	71	12	in	in	ADP
mkg-1066	71	13	hiv	hiv	PROPN
mkg-1066	71	14	-	-	PUNCT
mkg-1066	71	15	infected	infect	VERB
mkg-1066	71	16	patients	patient	NOUN
mkg-1066	71	17	:	:	PUNCT
mkg-1066	71	18	a	a	DET
mkg-1066	71	19	uk	uk	PROPN
mkg-1066	71	20	study	study	NOUN
mkg-1066	71	21	.	.	PUNCT
mkg-1066	72	1	oral	oral	ADJ
mkg-1066	72	2	surg	surg	NOUN
mkg-1066	72	3	oral	oral	ADJ
mkg-1066	72	4	med	med	ADJ
mkg-1066	72	5	oral	oral	ADJ
mkg-1066	72	6	pathol	pathol	NOUN
mkg-1066	72	7	radiol	radiol	PROPN
mkg-1066	72	8	endod	endod	PROPN
mkg-1066	72	9	2001	2001	NUM
mkg-1066	72	10	;	;	PUNCT
mkg-1066	72	11	92:623	92:623	NUM
mkg-1066	72	12	-	-	SYM
mkg-1066	72	13	8	8	NUM
mkg-1066	72	14	.	.	NOUN
mkg-1066	72	15	4	4	NUM
mkg-1066	72	16	.	.	X
mkg-1066	72	17	weller	weller	PROPN
mkg-1066	72	18	ivd	ivd	PROPN
mkg-1066	72	19	,	,	PUNCT
mkg-1066	72	20	williams	williams	PROPN
mkg-1066	72	21	ig	ig	PROPN
mkg-1066	72	22	.	.	PUNCT
mkg-1066	72	23	antiretroviral	antiretroviral	ADJ
mkg-1066	72	24	drugs	drug	NOUN
mkg-1066	72	25	.	.	PUNCT
mkg-1066	73	1	bmj	bmj	PROPN
mkg-1066	73	2	2001	2001	NUM
mkg-1066	73	3	;	;	PUNCT
mkg-1066	73	4	322:1410–12	322:1410–12	NUM
mkg-1066	73	5	.	.	NOUN
mkg-1066	73	6	5	5	NUM
mkg-1066	73	7	.	.	X
mkg-1066	74	1	sepkowitz	sepkowitz	PROPN
mkg-1066	74	2	ka	ka	PROPN
mkg-1066	74	3	.	.	PUNCT
mkg-1066	75	1	aidsthe	aidsthe	PRON
mkg-1066	75	2	first	first	ADJ
mkg-1066	75	3	20	20	NUM
mkg-1066	75	4	years	year	NOUN
mkg-1066	75	5	.	.	PUNCT
mkg-1066	76	1	n	n	PROPN
mkg-1066	77	1	engl	engl	PROPN
mkg-1066	77	2	j	j	PROPN
mkg-1066	77	3	med	med	PROPN
mkg-1066	77	4	2001	2001	NUM
mkg-1066	77	5	;	;	PUNCT
mkg-1066	77	6	344:1764–72	344:1764–72	NUM
mkg-1066	77	7	.	.	NOUN
mkg-1066	78	1	6	6	NUM
mkg-1066	78	2	.	.	X
mkg-1066	78	3	salobrena	salobrena	PROPN
mkg-1066	78	4	ac	ac	PROPN
mkg-1066	78	5	,	,	PUNCT
mkg-1066	78	6	cepeda	cepeda	PROPN
mkg-1066	78	7	lg	lg	PROPN
mkg-1066	78	8	,	,	PUNCT
mkg-1066	78	9	garria	garria	PROPN
mkg-1066	78	10	lc	lc	PROPN
mkg-1066	78	11	,	,	PUNCT
mkg-1066	78	12	samaranayaka	samaranayaka	ADV
mkg-1066	78	13	lp	lp	NOUN
mkg-1066	78	14	.	.	PUNCT
mkg-1066	79	1	the	the	DET
mkg-1066	79	2	effect	effect	NOUN
mkg-1066	79	3	of	of	ADP
mkg-1066	79	4	antiretroviral	antiretroviral	ADJ
mkg-1066	79	5	therapy	therapy	NOUN
mkg-1066	79	6	on	on	ADP
mkg-1066	79	7	the	the	DET
mkg-1066	79	8	prevalence	prevalence	NOUN
mkg-1066	79	9	of	of	ADP
mkg-1066	79	10	hiv	hiv	PROPN
mkg-1066	79	11	-	-	PUNCT
mkg-1066	79	12	associated	associate	VERB
mkg-1066	79	13	oral	oral	ADJ
mkg-1066	79	14	candidiasis	candidiasis	NOUN
mkg-1066	79	15	in	in	ADP
mkg-1066	79	16	a	a	DET
mkg-1066	79	17	spanish	spanish	ADJ
mkg-1066	79	18	cohort	cohort	NOUN
mkg-1066	79	19	.	.	PUNCT
mkg-1066	80	1	oral	oral	ADJ
mkg-1066	80	2	surg	surg	NOUN
mkg-1066	80	3	oral	oral	ADJ
mkg-1066	80	4	med	med	ADJ
mkg-1066	80	5	oral	oral	ADJ
mkg-1066	80	6	pathol	pathol	NOUN
mkg-1066	80	7	radiol	radiol	PROPN
mkg-1066	80	8	endod	endod	PROPN
mkg-1066	80	9	2004	2004	NUM
mkg-1066	80	10	;	;	PUNCT
mkg-1066	80	11	97:345–50	97:345–50	NOUN
mkg-1066	80	12	.	.	PUNCT
mkg-1066	81	1	7	7	X
mkg-1066	81	2	.	.	X
mkg-1066	81	3	mc	mc	PROPN
mkg-1066	81	4	carthy	carthy	PROPN
mkg-1066	81	5	gm	gm	PROPN
mkg-1066	81	6	.	.	PUNCT
mkg-1066	82	1	host	host	NOUN
mkg-1066	82	2	factors	factor	NOUN
mkg-1066	82	3	associated	associate	VERB
mkg-1066	82	4	with	with	ADP
mkg-1066	82	5	hiv	hiv	PROPN
mkg-1066	82	6	-	-	PUNCT
mkg-1066	82	7	related	relate	VERB
mkg-1066	82	8	oral	oral	ADJ
mkg-1066	82	9	candidiasis	candidiasis	NOUN
mkg-1066	82	10	.	.	PUNCT
mkg-1066	83	1	oral	oral	ADJ
mkg-1066	83	2	surg	surg	NOUN
mkg-1066	83	3	oral	oral	ADJ
mkg-1066	83	4	med	med	ADJ
mkg-1066	83	5	oral	oral	ADJ
mkg-1066	83	6	pathol	pathol	NOUN
mkg-1066	83	7	1992	1992	NUM
mkg-1066	83	8	;	;	PUNCT
mkg-1066	83	9	73:181–6	73:181–6	NUM
mkg-1066	83	10	.	.	NOUN
mkg-1066	83	11	8	8	NUM
mkg-1066	83	12	.	.	X
mkg-1066	84	1	patton	patton	PROPN
mkg-1066	84	2	ll	ll	PROPN
mkg-1066	84	3	,	,	PUNCT
mkg-1066	84	4	mckaig	mckaig	PROPN
mkg-1066	84	5	rg	rg	PROPN
mkg-1066	84	6	,	,	PUNCT
mkg-1066	84	7	strauss	strauss	PROPN
mkg-1066	84	8	rp	rp	PROPN
mkg-1066	84	9	,	,	PUNCT
mkg-1066	84	10	eron	eron	PROPN
mkg-1066	84	11	jr	jr	PROPN
mkg-1066	84	12	jj	jj	PROPN
mkg-1066	84	13	.	.	PROPN
mkg-1066	84	14	oral	oral	ADJ
mkg-1066	84	15	manifestations	manifestation	NOUN
mkg-1066	84	16	of	of	ADP
mkg-1066	84	17	hiv	hiv	PROPN
mkg-1066	84	18	in	in	ADP
mkg-1066	84	19	a	a	DET
mkg-1066	84	20	southeast	southeast	PROPN
mkg-1066	84	21	usa	usa	PROPN
mkg-1066	84	22	population	population	NOUN
mkg-1066	84	23	.	.	PUNCT
mkg-1066	85	1	oral	oral	ADJ
mkg-1066	85	2	dis	dis	PROPN
mkg-1066	85	3	1998	1998	NUM
mkg-1066	85	4	;	;	PUNCT
mkg-1066	85	5	4:164–9	4:164–9	X
mkg-1066	85	6	.	.	NOUN
mkg-1066	85	7	9	9	NUM
mkg-1066	85	8	.	.	X
mkg-1066	86	1	patton	patton	PROPN
mkg-1066	86	2	ll	ll	PROPN
mkg-1066	86	3	,	,	PUNCT
mkg-1066	86	4	mccaig	mccaig	PROPN
mkg-1066	86	5	rg	rg	PROPN
mkg-1066	86	6	,	,	PUNCT
mkg-1066	86	7	strauss	strauss	PROPN
mkg-1066	86	8	rp	rp	PROPN
mkg-1066	86	9	,	,	PUNCT
mkg-1066	86	10	rogers	rogers	PROPN
mkg-1066	86	11	d	d	PROPN
mkg-1066	86	12	,	,	PUNCT
mkg-1066	86	13	eron	eron	PROPN
mkg-1066	86	14	jr	jr	PROPN
mkg-1066	86	15	jj	jj	PROPN
mkg-1066	86	16	.	.	PUNCT
mkg-1066	86	17	changing	change	VERB
mkg-1066	86	18	prevalence	prevalence	NOUN
mkg-1066	86	19	of	of	ADP
mkg-1066	86	20	oral	oral	ADJ
mkg-1066	86	21	manifestations	manifestation	NOUN
mkg-1066	86	22	of	of	ADP
mkg-1066	86	23	human	human	ADJ
mkg-1066	86	24	immunodeficiency	immunodeficiency	NOUN
mkg-1066	86	25	virus	virus	NOUN
mkg-1066	86	26	in	in	ADP
mkg-1066	86	27	the	the	DET
mkg-1066	86	28	era	era	NOUN
mkg-1066	86	29	of	of	ADP
mkg-1066	86	30	protease	protease	NOUN
mkg-1066	86	31	inhibitior	inhibitior	NOUN
mkg-1066	86	32	therapy	therapy	NOUN
mkg-1066	86	33	.	.	PUNCT
mkg-1066	87	1	oral	oral	ADJ
mkg-1066	87	2	surg	surg	NOUN
mkg-1066	87	3	oral	oral	ADJ
mkg-1066	87	4	med	med	ADJ
mkg-1066	87	5	oral	oral	ADJ
mkg-1066	87	6	pathol	pathol	NOUN
mkg-1066	87	7	oral	oral	ADJ
mkg-1066	87	8	radiol	radiol	NOUN
mkg-1066	87	9	endod	endod	PROPN
mkg-1066	87	10	2000	2000	NUM
mkg-1066	87	11	;	;	PUNCT
mkg-1066	87	12	89:299–304	89:299–304	PROPN
mkg-1066	87	13	.	.	PUNCT
mkg-1066	88	1	10	10	NUM
mkg-1066	88	2	.	.	PUNCT
mkg-1066	88	3	samaranayake	samaranayake	PROPN
mkg-1066	88	4	lp	lp	PROPN
mkg-1066	88	5	.	.	PUNCT
mkg-1066	89	1	oral	oral	ADJ
mkg-1066	89	2	mycosis	mycosis	NOUN
mkg-1066	89	3	in	in	ADP
mkg-1066	89	4	hiv	hiv	PROPN
mkg-1066	89	5	infection	infection	NOUN
mkg-1066	89	6	.	.	PUNCT
mkg-1066	90	1	oral	oral	ADJ
mkg-1066	90	2	surg	surg	NOUN
mkg-1066	90	3	oral	oral	ADJ
mkg-1066	90	4	med	med	ADJ
mkg-1066	90	5	oral	oral	ADJ
mkg-1066	90	6	pathol	pathol	NOUN
mkg-1066	90	7	1992	1992	NUM
mkg-1066	90	8	;	;	PUNCT
mkg-1066	90	9	73:171–80	73:171–80	PROPN
mkg-1066	90	10	.	.	PUNCT
mkg-1066	91	1	11	11	NUM
mkg-1066	91	2	.	.	PUNCT
mkg-1066	92	1	migliorati	migliorati	PROPN
mkg-1066	92	2	ca	ca	PROPN
mkg-1066	92	3	,	,	PUNCT
mkg-1066	92	4	birman	birman	NOUN
mkg-1066	92	5	eg	eg	NOUN
mkg-1066	92	6	,	,	PUNCT
mkg-1066	92	7	cury	cury	PROPN
mkg-1066	92	8	ae	ae	PROPN
mkg-1066	92	9	.	.	PUNCT
mkg-1066	93	1	oropharyngeal	oropharyngeal	ADJ
mkg-1066	93	2	candidiasis	candidiasis	NOUN
mkg-1066	93	3	in	in	ADP
mkg-1066	93	4	hiv	hiv	PROPN
mkg-1066	93	5	-	-	PUNCT
mkg-1066	93	6	infected	infect	VERB
mkg-1066	93	7	patients	patient	NOUN
mkg-1066	93	8	under	under	ADP
mkg-1066	93	9	treatment	treatment	NOUN
mkg-1066	93	10	with	with	ADP
mkg-1066	93	11	protease	protease	NOUN
mkg-1066	93	12	inhibitors	inhibitor	NOUN
mkg-1066	93	13	.	.	PUNCT
mkg-1066	94	1	oral	oral	ADJ
mkg-1066	94	2	surg	surg	NOUN
mkg-1066	94	3	oral	oral	ADJ
mkg-1066	94	4	med	med	ADJ
mkg-1066	94	5	oral	oral	ADJ
mkg-1066	94	6	pathol	pathol	NOUN
mkg-1066	94	7	oral	oral	ADJ
mkg-1066	94	8	radiol	radiol	NOUN
mkg-1066	94	9	endod	endod	PROPN
mkg-1066	94	10	2004	2004	NUM
mkg-1066	94	11	;	;	PUNCT
mkg-1066	94	12	98:301–10	98:301–10	NUM
mkg-1066	94	13	.	.	PUNCT
mkg-1066	95	1	12	12	NUM
mkg-1066	95	2	.	.	PUNCT
mkg-1066	96	1	romagnoli	romagnoli	PROPN
mkg-1066	96	2	p	p	NOUN
mkg-1066	96	3	,	,	PUNCT
mkg-1066	96	4	pimpinelli	pimpinelli	PROPN
mkg-1066	96	5	n	n	CCONJ
mkg-1066	96	6	,	,	PUNCT
mkg-1066	96	7	reichart	reichart	PROPN
mkg-1066	96	8	pa	pa	PROPN
mkg-1066	96	9	,	,	PUNCT
mkg-1066	96	10	eversole	eversole	NOUN
mkg-1066	96	11	lr	lr	PROPN
mkg-1066	96	12	,	,	PUNCT
mkg-1066	96	13	ficarra	ficarra	ADJ
mkg-1066	96	14	g.	g.	PROPN
mkg-1066	96	15	immunocompetent	immunocompetent	ADJ
mkg-1066	96	16	cells	cell	NOUN
mkg-1066	96	17	in	in	ADP
mkg-1066	96	18	oral	oral	ADJ
mkg-1066	96	19	candidiasis	candidiasis	NOUN
mkg-1066	96	20	of	of	ADP
mkg-1066	96	21	hiv	hiv	PROPN
mkg-1066	96	22	-	-	PUNCT
mkg-1066	96	23	infected	infect	VERB
mkg-1066	96	24	patients	patient	NOUN
mkg-1066	96	25	:	:	PUNCT
mkg-1066	96	26	an	an	DET
mkg-1066	96	27	immunohistochemical	immunohistochemical	ADJ
mkg-1066	96	28	and	and	CCONJ
mkg-1066	96	29	electron	electron	NOUN
mkg-1066	96	30	microscopical	microscopical	ADJ
mkg-1066	96	31	study	study	NOUN
mkg-1066	96	32	.	.	PUNCT
mkg-1066	97	1	oral	oral	ADJ
mkg-1066	97	2	dis	dis	PROPN
mkg-1066	97	3	1997	1997	NUM
mkg-1066	97	4	;	;	PUNCT
mkg-1066	97	5	3:99–105	3:99–105	NUM
mkg-1066	97	6	.	.	PUNCT
mkg-1066	98	1	13	13	NUM
mkg-1066	98	2	.	.	PUNCT
mkg-1066	99	1	lin	lin	PROPN
mkg-1066	99	2	al	al	PROPN
mkg-1066	99	3	,	,	PUNCT
mkg-1066	99	4	johnson	johnson	PROPN
mkg-1066	99	5	da	da	PROPN
mkg-1066	99	6	,	,	PUNCT
mkg-1066	99	7	paterson	paterson	PROPN
mkg-1066	99	8	tf	tf	PROPN
mkg-1066	99	9	,	,	PUNCT
mkg-1066	99	10	wu	wu	PROPN
mkg-1066	99	11	y	y	PROPN
mkg-1066	99	12	,	,	PUNCT
mkg-1066	99	13	lu	lu	PROPN
mkg-1066	99	14	dl	dl	PROPN
mkg-1066	99	15	,	,	PUNCT
mkg-1066	99	16	shi	shi	PROPN
mkg-1066	99	17	q	q	PROPN
mkg-1066	99	18	,	,	PUNCT
mkg-1066	99	19	yeh	yeh	PROPN
mkg-1066	99	20	ck	ck	PROPN
mkg-1066	99	21	.	.	PUNCT
mkg-1066	100	1	salivary	salivary	VERB
mkg-1066	100	2	anticandidal	anticandidal	ADJ
mkg-1066	100	3	activity	activity	NOUN
mkg-1066	100	4	and	and	CCONJ
mkg-1066	100	5	saliva	saliva	NOUN
mkg-1066	100	6	composition	composition	NOUN
mkg-1066	100	7	in	in	ADP
mkg-1066	100	8	an	an	DET
mkg-1066	100	9	hivinfected	hivinfected	ADJ
mkg-1066	100	10	cohort	cohort	NOUN
mkg-1066	100	11	.	.	PUNCT
mkg-1066	101	1	oral	oral	ADJ
mkg-1066	101	2	microbiol	microbiol	PROPN
mkg-1066	101	3	immunol	immunol	NOUN
mkg-1066	101	4	2001	2001	NUM
mkg-1066	101	5	;	;	PUNCT
mkg-1066	101	6	16:270–8	16:270–8	NUM
mkg-1066	101	7	.	.	PUNCT
mkg-1066	101	8	�	�	PROPN
mkg-1066	101	9	�	�	PROPN
mkg-1066	101	10	hasibuan	hasibuan	PROPN
mkg-1066	101	11	:	:	PUNCT
mkg-1066	101	12	effect	effect	NOUN
mkg-1066	101	13	of	of	ADP
mkg-1066	101	14	combination	combination	NOUN
mkg-1066	101	15	antiretroviral	antiretroviral	ADJ
mkg-1066	101	16	therapi	therapi	NOUN
mkg-1066	101	17	14	14	NUM
mkg-1066	101	18	.	.	PUNCT
mkg-1066	102	1	cassone	cassone	PROPN
mkg-1066	102	2	a	a	PRON
mkg-1066	102	3	,	,	PUNCT
mkg-1066	102	4	tacconelli	tacconelli	NOUN
mkg-1066	102	5	e	e	NOUN
mkg-1066	102	6	,	,	PUNCT
mkg-1066	102	7	debernardis	debernardi	VERB
mkg-1066	102	8	f	f	PROPN
mkg-1066	102	9	,	,	PUNCT
mkg-1066	102	10	tumbarello	tumbarello	PROPN
mkg-1066	102	11	m	m	PROPN
mkg-1066	102	12	,	,	PUNCT
mkg-1066	102	13	torosanfucci	torosanfucci	VERB
mkg-1066	102	14	a	a	PRON
mkg-1066	102	15	,	,	PUNCT
mkg-1066	102	16	chiani	chiani	NOUN
mkg-1066	102	17	p	p	X
mkg-1066	102	18	,	,	PUNCT
mkg-1066	102	19	cauda	cauda	PROPN
mkg-1066	102	20	r.	r.	PROPN
mkg-1066	102	21	antiretroviral	antiretroviral	PROPN
mkg-1066	102	22	therapy	therapy	NOUN
mkg-1066	102	23	with	with	ADP
mkg-1066	102	24	protease	protease	NOUN
mkg-1066	102	25	inhibitors	inhibitor	NOUN
mkg-1066	102	26	has	have	VERB
mkg-1066	102	27	an	an	DET
mkg-1066	102	28	early	early	ADJ
mkg-1066	102	29	,	,	PUNCT
mkg-1066	102	30	immune	immune	ADJ
mkg-1066	102	31	reconstitutionindependent	reconstitutionindependent	NOUN
mkg-1066	102	32	beneficial	beneficial	ADJ
mkg-1066	102	33	effects	effect	NOUN
mkg-1066	102	34	on	on	ADP
mkg-1066	102	35	candida	candida	PROPN
mkg-1066	102	36	virulence	virulence	NOUN
mkg-1066	102	37	and	and	CCONJ
mkg-1066	102	38	oral	oral	ADJ
mkg-1066	102	39	candidiasis	candidiasis	NOUN
mkg-1066	102	40	in	in	ADP
mkg-1066	102	41	human	human	ADJ
mkg-1066	102	42	immunodeficiency	immunodeficiency	NOUN
mkg-1066	102	43	virus	virus	NOUN
mkg-1066	102	44	infected	infect	VERB
mkg-1066	102	45	subjects	subject	NOUN
mkg-1066	102	46	.	.	PUNCT
mkg-1066	103	1	j	j	PROPN
mkg-1066	103	2	infec	infec	PROPN
mkg-1066	103	3	dis	dis	PROPN
mkg-1066	103	4	2002	2002	NUM
mkg-1066	103	5	;	;	PUNCT
mkg-1066	103	6	185:188–95	185:188–95	NUM
mkg-1066	103	7	.	.	PUNCT
mkg-1066	104	1	15	15	NUM
mkg-1066	104	2	.	.	PUNCT
mkg-1066	105	1	baqui	baqui	NOUN
mkg-1066	105	2	aama	aama	NOUN
mkg-1066	105	3	,	,	PUNCT
mkg-1066	105	4	meiler	meiler	NOUN
mkg-1066	105	5	tf	tf	PROPN
mkg-1066	105	6	,	,	PUNCT
mkg-1066	105	7	jaber	jaber	PROPN
mkg-1066	105	8	-	-	PUNCT
mkg-1066	105	9	rizk	rizk	PROPN
mkg-1066	105	10	ma	ma	PROPN
mkg-1066	105	11	,	,	PUNCT
mkg-1066	105	12	zhang	zhang	PROPN
mkg-1066	105	13	m	m	PROPN
mkg-1066	105	14	,	,	PUNCT
mkg-1066	105	15	kelley	kelley	PROPN
mkg-1066	105	16	jf	jf	PROPN
mkg-1066	105	17	,	,	PUNCT
mkg-1066	105	18	falkler	falkler	X
mkg-1066	105	19	wa	wa	PROPN
mkg-1066	105	20	.	.	PROPN
mkg-1066	105	21	association	association	PROPN
mkg-1066	105	22	on	on	ADP
mkg-1066	105	23	hiv	hiv	PROPN
mkg-1066	105	24	viral	viral	ADJ
mkg-1066	105	25	load	load	NOUN
mkg-1066	105	26	with	with	ADP
mkg-1066	105	27	oral	oral	ADJ
mkg-1066	105	28	diseases	disease	NOUN
mkg-1066	105	29	.	.	PUNCT
mkg-1066	106	1	oral	oral	ADJ
mkg-1066	106	2	dis	dis	PROPN
mkg-1066	106	3	1999	1999	NUM
mkg-1066	106	4	;	;	PUNCT
mkg-1066	106	5	5:294–8	5:294–8	X
mkg-1066	106	6	.	.	NOUN
mkg-1066	106	7	16	16	NUM
mkg-1066	106	8	.	.	PUNCT
mkg-1066	107	1	dios	dios	PROPN
mkg-1066	107	2	pd	pd	PROPN
mkg-1066	107	3	,	,	PUNCT
mkg-1066	107	4	ocampo	ocampo	X
mkg-1066	107	5	a	a	PRON
mkg-1066	107	6	,	,	PUNCT
mkg-1066	107	7	miralles	miralle	NOUN
mkg-1066	107	8	c	c	NOUN
mkg-1066	107	9	,	,	PUNCT
mkg-1066	107	10	otero	otero	PROPN
mkg-1066	108	1	i	i	PROPN
mkg-1066	108	2	,	,	PUNCT
mkg-1066	108	3	iglesias	iglesias	PROPN
mkg-1066	108	4	i	i	PROPN
mkg-1066	108	5	,	,	PUNCT
mkg-1066	108	6	rayo	rayo	NOUN
mkg-1066	108	7	n.	n.	PROPN
mkg-1066	108	8	frequency	frequency	NOUN
mkg-1066	108	9	of	of	ADP
mkg-1066	108	10	oropharyngeal	oropharyngeal	ADJ
mkg-1066	108	11	candidiasis	candidiasis	NOUN
mkg-1066	108	12	in	in	ADP
mkg-1066	108	13	hiv	hiv	PROPN
mkg-1066	108	14	-	-	PUNCT
mkg-1066	108	15	infected	infect	VERB
mkg-1066	108	16	patients	patient	NOUN
mkg-1066	108	17	on	on	ADP
mkg-1066	108	18	protease	protease	NOUN
mkg-1066	108	19	inhibitor	inhibitor	NOUN
mkg-1066	108	20	therapy	therapy	NOUN
mkg-1066	108	21	.	.	PUNCT
mkg-1066	109	1	oral	oral	ADJ
mkg-1066	109	2	surg	surg	NOUN
mkg-1066	109	3	oral	oral	ADJ
mkg-1066	109	4	med	med	ADJ
mkg-1066	109	5	oral	oral	ADJ
mkg-1066	109	6	pathol	pathol	NOUN
mkg-1066	109	7	oral	oral	ADJ
mkg-1066	109	8	radiol	radiol	NOUN
mkg-1066	109	9	endod	endod	PROPN
mkg-1066	109	10	1999	1999	NUM
mkg-1066	109	11	;	;	PUNCT
mkg-1066	109	12	87:437–41	87:437–41	NOUN
mkg-1066	109	13	.	.	PUNCT
mkg-1066	110	1	17	17	NUM
mkg-1066	110	2	.	.	X
mkg-1066	111	1	naglick	naglick	PROPN
mkg-1066	111	2	jr	jr	PROPN
mkg-1066	111	3	,	,	PUNCT
mkg-1066	111	4	challombe	challombe	NOUN
mkg-1066	111	5	sj	sj	PROPN
mkg-1066	111	6	,	,	PUNCT
mkg-1066	111	7	hube	hube	PROPN
mkg-1066	111	8	b.	b.	PROPN
mkg-1066	111	9	candida	candida	PROPN
mkg-1066	111	10	albican	albican	PROPN
mkg-1066	111	11	secreted	secrete	VERB
mkg-1066	111	12	aspartyl	aspartyl	NOUN
mkg-1066	111	13	proteinasses	proteinasse	NOUN
mkg-1066	111	14	in	in	ADP
mkg-1066	111	15	virulence	virulence	NOUN
mkg-1066	111	16	and	and	CCONJ
mkg-1066	111	17	pathogenesis	pathogenesis	NOUN
mkg-1066	111	18	.	.	PUNCT
mkg-1066	112	1	microbiology	microbiology	NOUN
mkg-1066	112	2	and	and	CCONJ
mkg-1066	112	3	molecular	molecular	ADJ
mkg-1066	112	4	biology	biology	NOUN
mkg-1066	112	5	virus	virus	NOUN
mkg-1066	112	6	.	.	PUNCT
mkg-1066	113	1	2003	2003	NUM
mkg-1066	113	2	.	.	PUNCT
mkg-1066	114	1	available	available	ADJ
mkg-1066	114	2	at	at	ADP
mkg-1066	114	3	:	:	PUNCT
mkg-1066	114	4	http://www.mmbr	http://www.mmbr	NOUN
mkg-1066	114	5	.	.	PUNCT
mkg-1066	115	1	a5m.org/cgi/content/full/67/3/400	a5m.org/cgi/content/full/67/3/400	ADV
mkg-1066	115	2	.	.	PUNCT
mkg-1066	116	1	accessed	access	VERB
mkg-1066	116	2	march	march	PROPN
mkg-1066	116	3	27	27	NUM
mkg-1066	116	4	,	,	PUNCT
mkg-1066	116	5	2005	2005	NUM
mkg-1066	116	6	.	.	PUNCT
mkg-1066	117	1	18	18	NUM
mkg-1066	117	2	.	.	PUNCT
mkg-1066	117	3	montaner	montaner	PROPN
mkg-1066	117	4	jsg	jsg	PROPN
mkg-1066	117	5	,	,	PUNCT
mkg-1066	117	6	hogg	hogg	PROPN
mkg-1066	117	7	r	r	PROPN
mkg-1066	117	8	,	,	PUNCT
mkg-1066	117	9	raboud	raboud	PROPN
mkg-1066	117	10	j	j	PROPN
mkg-1066	117	11	,	,	PUNCT
mkg-1066	117	12	harigan	harigan	NOUN
mkg-1066	117	13	r	r	NOUN
mkg-1066	117	14	,	,	PUNCT
mkg-1066	117	15	o’shaughnessy	o’shaughnessy	PROPN
mkg-1066	117	16	.	.	PUNCT
mkg-1066	117	17	antiretroviral	antiretroviral	ADJ
mkg-1066	117	18	treatment	treatment	NOUN
mkg-1066	117	19	in	in	ADP
mkg-1066	117	20	1998	1998	NUM
mkg-1066	117	21	.	.	PUNCT
mkg-1066	118	1	the	the	DET
mkg-1066	118	2	lancet	lancet	NOUN
mkg-1066	118	3	1998	1998	NUM
mkg-1066	118	4	;	;	PUNCT
mkg-1066	118	5	352:1919–22	352:1919–22	NUM
mkg-1066	118	6	.	.	NOUN
mkg-1066	118	7	19	19	NUM
mkg-1066	118	8	.	.	PUNCT
mkg-1066	118	9	lewin	lewin	PROPN
mkg-1066	118	10	sr	sr	PROPN
mkg-1066	118	11	,	,	PUNCT
mkg-1066	118	12	crowe	crowe	PROPN
mkg-1066	118	13	s	s	PROPN
mkg-1066	118	14	,	,	PUNCT
mkg-1066	118	15	chambers	chamber	NOUN
mkg-1066	118	16	de	de	X
mkg-1066	118	17	,	,	PUNCT
mkg-1066	118	18	cooper	cooper	PROPN
mkg-1066	118	19	da	da	PROPN
mkg-1066	118	20	.	.	PROPN
mkg-1066	119	1	antiretroviral	antiretroviral	ADJ
mkg-1066	119	2	therapies	therapy	NOUN
mkg-1066	119	3	for	for	ADP
mkg-1066	119	4	hiv	hiv	PROPN
mkg-1066	119	5	.	.	PUNCT
mkg-1066	120	1	melborne	melborne	NOUN
mkg-1066	120	2	:	:	PUNCT
mkg-1066	120	3	pubmed	pubmed	PROPN
mkg-1066	120	4	2000	2000	NUM
mkg-1066	120	5	;	;	PUNCT
mkg-1066	121	1	p.	p.	PROPN
mkg-1066	121	2	45–54	45–54	NUM
mkg-1066	121	3	.	.	PROPN
mkg-1066	122	1	20	20	NUM
mkg-1066	122	2	.	.	PUNCT
mkg-1066	123	1	bangsberg	bangsberg	PROPN
mkg-1066	123	2	d	d	PROPN
mkg-1066	123	3	,	,	PUNCT
mkg-1066	123	4	tulshy	tulshy	ADJ
mkg-1066	123	5	jp	jp	NOUN
mkg-1066	123	6	,	,	PUNCT
mkg-1066	123	7	hecht	hecht	PROPN
mkg-1066	123	8	fm	fm	PROPN
mkg-1066	123	9	,	,	PUNCT
mkg-1066	123	10	moss	moss	PROPN
mkg-1066	123	11	ar	ar	PROPN
mkg-1066	123	12	.	.	PROPN
mkg-1066	123	13	protease	protease	NOUN
mkg-1066	123	14	inhibitor	inhibitor	NOUN
mkg-1066	123	15	in	in	ADP
mkg-1066	123	16	the	the	DET
mkg-1066	123	17	homeless	homeless	NOUN
mkg-1066	123	18	.	.	PUNCT
mkg-1066	124	1	jama	jama	PROPN
mkg-1066	124	2	1997	1997	NUM
mkg-1066	124	3	;	;	PUNCT
mkg-1066	124	4	278:63–5	278:63–5	NUM
mkg-1066	124	5	.	.	NOUN
mkg-1066	124	6	21	21	NUM
mkg-1066	124	7	.	.	X
mkg-1066	124	8	aquirre	aquirre	PROPN
mkg-1066	124	9	jm	jm	PROPN
mkg-1066	124	10	,	,	PUNCT
mkg-1066	124	11	echebarria	echebarria	PROPN
mkg-1066	124	12	ma	ma	PROPN
mkg-1066	124	13	,	,	PUNCT
mkg-1066	124	14	ocina	ocina	PROPN
mkg-1066	124	15	e	e	PROPN
mkg-1066	124	16	,	,	PUNCT
mkg-1066	124	17	ribacoba	ribacoba	PROPN
mkg-1066	124	18	l	l	PROPN
mkg-1066	124	19	,	,	PUNCT
mkg-1066	124	20	montejo	montejo	PROPN
mkg-1066	124	21	m.	m.	NOUN
mkg-1066	124	22	reduction	reduction	NOUN
mkg-1066	124	23	of	of	ADP
mkg-1066	124	24	hiv	hiv	PROPN
mkg-1066	124	25	-	-	PUNCT
mkg-1066	124	26	associated	associate	VERB
mkg-1066	124	27	oral	oral	ADJ
mkg-1066	124	28	lesions	lesion	NOUN
mkg-1066	124	29	ahter	ahter	NOUN
mkg-1066	124	30	highly	highly	ADV
mkg-1066	124	31	active	active	ADJ
mkg-1066	124	32	antiretroviral	antiretroviral	ADJ
mkg-1066	124	33	therapy	therapy	NOUN
mkg-1066	124	34	.	.	PUNCT
mkg-1066	125	1	oral	oral	ADJ
mkg-1066	125	2	surg	surg	NOUN
mkg-1066	125	3	oral	oral	ADJ
mkg-1066	125	4	med	med	ADJ
mkg-1066	125	5	oral	oral	ADJ
mkg-1066	125	6	pathol	pathol	NOUN
mkg-1066	125	7	oral	oral	ADJ
mkg-1066	125	8	radiol	radiol	NOUN
mkg-1066	125	9	endod	endod	PROPN
mkg-1066	125	10	1999	1999	NUM
mkg-1066	125	11	;	;	PUNCT
mkg-1066	125	12	88:1–3	88:1–3	NUM
mkg-1066	125	13	.	.	PUNCT
mkg-1066	126	1	22	22	NUM
mkg-1066	126	2	.	.	PUNCT
mkg-1066	127	1	chattopadhyay	chattopadhyay	PROPN
mkg-1066	127	2	a	a	PROPN
mkg-1066	127	3	,	,	PUNCT
mkg-1066	127	4	jouen	jouen	PROPN
mkg-1066	127	5	d	d	PROPN
mkg-1066	127	6	,	,	PUNCT
mkg-1066	127	7	caplan	caplan	PROPN
mkg-1066	127	8	dj	dj	PROPN
mkg-1066	127	9	,	,	PUNCT
mkg-1066	127	10	slade	slade	PROPN
mkg-1066	127	11	gd	gd	PROPN
mkg-1066	127	12	,	,	PUNCT
mkg-1066	127	13	shugars	shugar	VERB
mkg-1066	127	14	dc	dc	PROPN
mkg-1066	127	15	,	,	PUNCT
mkg-1066	127	16	tien	tien	PROPN
mkg-1066	127	17	hc	hc	PROPN
mkg-1066	127	18	,	,	PUNCT
mkg-1066	127	19	patton	patton	PROPN
mkg-1066	127	20	ll	ll	NOUN
mkg-1066	127	21	.	.	PUNCT
mkg-1066	128	1	incidence	incidence	NOUN
mkg-1066	128	2	of	of	ADP
mkg-1066	128	3	oral	oral	ADJ
mkg-1066	128	4	candidiasis	candidiasis	NOUN
mkg-1066	128	5	and	and	CCONJ
mkg-1066	128	6	oral	oral	ADJ
mkg-1066	128	7	hairy	hairy	ADJ
mkg-1066	128	8	leukoplakia	leukoplakia	NOUN
mkg-1066	128	9	in	in	ADP
mkg-1066	128	10	hiv	hiv	PROPN
mkg-1066	128	11	-	-	PUNCT
mkg-1066	128	12	infected	infect	VERB
mkg-1066	128	13	adults	adult	NOUN
mkg-1066	128	14	in	in	ADP
mkg-1066	128	15	north	north	PROPN
mkg-1066	128	16	carolina	carolina	PROPN
mkg-1066	128	17	.	.	PUNCT
mkg-1066	129	1	oral	oral	ADJ
mkg-1066	129	2	surg	surg	NOUN
mkg-1066	129	3	oral	oral	ADJ
mkg-1066	129	4	med	med	ADJ
mkg-1066	129	5	oral	oral	ADJ
mkg-1066	129	6	pathol	pathol	NOUN
mkg-1066	129	7	oral	oral	ADJ
mkg-1066	129	8	radiol	radiol	NOUN
mkg-1066	129	9	endod	endod	PROPN
mkg-1066	129	10	2001	2001	NUM
mkg-1066	129	11	;	;	PUNCT
mkg-1066	129	12	92:623–8	92:623–8	NUM
mkg-1066	129	13	.	.	X
mkg-1066	130	1	23	23	NUM
mkg-1066	130	2	.	.	PUNCT
mkg-1066	131	1	dios	dios	PROPN
mkg-1066	131	2	pd	pd	PROPN
mkg-1066	131	3	,	,	PUNCT
mkg-1066	131	4	ocampo	ocampo	X
mkg-1066	131	5	a	a	PRON
mkg-1066	131	6	,	,	PUNCT
mkg-1066	131	7	miralles	miralle	NOUN
mkg-1066	131	8	c	c	NOUN
mkg-1066	131	9	,	,	PUNCT
mkg-1066	131	10	limeres	limere	VERB
mkg-1066	131	11	j	j	PROPN
mkg-1066	131	12	,	,	PUNCT
mkg-1066	131	13	tomas	tomas	PROPN
mkg-1066	131	14	i.	i.	PROPN
mkg-1066	131	15	changing	change	VERB
mkg-1066	131	16	prevalence	prevalence	NOUN
mkg-1066	131	17	of	of	ADP
mkg-1066	131	18	human	human	ADJ
mkg-1066	131	19	immunodeficiency	immunodeficiency	NOUN
mkg-1066	131	20	virus	virus	NOUN
mkg-1066	131	21	-	-	PUNCT
mkg-1066	131	22	associated	associate	VERB
mkg-1066	131	23	oral	oral	ADJ
mkg-1066	131	24	lesions	lesion	NOUN
mkg-1066	131	25	.	.	PUNCT
mkg-1066	132	1	oral	oral	ADJ
mkg-1066	132	2	surg	surg	NOUN
mkg-1066	132	3	oral	oral	ADJ
mkg-1066	132	4	med	med	ADJ
mkg-1066	132	5	oral	oral	ADJ
mkg-1066	132	6	pathol	pathol	NOUN
mkg-1066	132	7	oral	oral	ADJ
mkg-1066	132	8	radiol	radiol	NOUN
mkg-1066	132	9	endod	endod	PROPN
mkg-1066	132	10	2000	2000	NUM
mkg-1066	132	11	;	;	PUNCT
mkg-1066	132	12	90:403–5	90:403–5	NUM
mkg-1066	132	13	.	.	NOUN
mkg-1066	132	14	24	24	NUM
mkg-1066	132	15	.	.	PUNCT
mkg-1066	133	1	frezzini	frezzini	PROPN
mkg-1066	133	2	c	c	PROPN
mkg-1066	133	3	,	,	PUNCT
mkg-1066	133	4	leao	leao	PROPN
mkg-1066	133	5	jc	jc	PROPN
mkg-1066	133	6	,	,	PUNCT
mkg-1066	133	7	porter	porter	PROPN
mkg-1066	133	8	s.	s.	PROPN
mkg-1066	133	9	current	current	ADJ
mkg-1066	133	10	trends	trend	NOUN
mkg-1066	133	11	of	of	ADP
mkg-1066	133	12	hiv	hiv	PROPN
mkg-1066	133	13	disease	disease	NOUN
mkg-1066	133	14	of	of	ADP
mkg-1066	133	15	the	the	DET
mkg-1066	133	16	mouth	mouth	NOUN
mkg-1066	133	17	.	.	PUNCT
mkg-1066	134	1	j	j	PROPN
mkg-1066	134	2	oral	oral	ADJ
mkg-1066	134	3	pathol	pathol	NOUN
mkg-1066	134	4	med	me	VERB
mkg-1066	134	5	2005	2005	NUM
mkg-1066	134	6	;	;	PUNCT
mkg-1066	134	7	34:513–31	34:513–31	NUM
mkg-1066	134	8	.	.	PUNCT